DrugBank ID,Name,Drug Groups,SMILES,Formula,Doping,Drug Categories,Target_Names
DB00014,Goserelin,approved,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,C59H84N18O14,1,"Adrenal Cortex Hormones, Amino Acids, Peptides, and Proteins, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, Drugs that are Mainly Renally Excreted, Endocrine Therapy, Gonadotropin Releasing Hormone Receptor Agonist, Gonadotropin Releasing Hormone Receptor Agonists, Gonadotropin-releasing hormone agonist, Gonadotropins and Antigonadotropins, Hormones, Hormones and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Hypothalamic Hormones, Miscellaneous Therapeutic Agents, Moderate Risk QTc-Prolonging Agents, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Pituitary Hormone-Releasing Hormones, QTc Prolonging Agents"," Lutropin-choriogonadotropic hormone receptor,  Gonadotropin-releasing hormone receptor"
DB00035,Desmopressin,approved,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,C46H64N14O12S2,1,"Agents that produce hypertension, Amino Acids, Peptides, and Proteins, Antidiuretic Agents, Arginine Vasopressin, Cardiovascular Agents, Coagulants, Drugs that are Mainly Renally Excreted, Factor VIII Activator, Hematologic Agents, Hemostatics, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Increased Coagulation Factor VIII Activity, Increased Coagulation Factor VIII Concentration, Natriuretic Agents, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Pituitary, Pituitary and Hypothalamic Hormones and Analogues, Pituitary Hormones, Pituitary Hormones, Posterior, Posterior Pituitary Lobe Hormones, Proteins, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Vasopressin Analog, Vasopressin and Analogues, Vasopressins"," Vasopressin V2 receptor,  Vasopressin V1a receptor,  Vasopressin V1b receptor,  Prostaglandin G/H synthase 2,  Prostaglandin G/H synthase 1"
DB11323,Glycol salicylate,approved,OCCOC(=O)C1=CC=CC=C1O,C9H10O4,1,"Acids, Carbocyclic, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Benzene Derivatives, Benzoates, Hydroxy Acids, Hydroxybenzoates, Phenols"," Prostaglandin G/H synthase 1,  Prostaglandin G/H synthase 2"
DB07447,5beta-dihydrotestosterone,experimental,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,C19H30O2,1,Testosterone and derivatives, 3-oxo-5-beta-steroid 4-dehydrogenase
DB13758,Meclofenoxate,experimental,CN(C)CCOC(=O)COC1=CC=C(Cl)C=C1,C12H16ClNO3,1,"Acetates, Acids, Acyclic, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Glycolates, Hydroxy Acids, Nervous System, Neuroprotective Agents, Nootropic Agents, Phenoxyacetates, Protective Agents, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics",
DB07467,(S)-Indapamide,experimental,C[C@H]1CC2=C(C=CC=C2)N1NC(=O)C1=CC=C(Cl)C(=C1)S(N)(=O)=O,C16H16ClN3O3S,1,, Carbonic anhydrase 2
DB02327,Triethylene glycol,experimental,OCCOCCOCCO,C6H14O4,1,"Alcohols, Compounds used in a research, industrial, or household setting, Ethylene Glycols, Glycols, Macromolecular Substances, Polymers"," Acetolactate synthase, catabolic,  Arabinogalactan endo-1,4-beta-galactosidase,  Phosphoserine aminotransferase"
DB17692,Vamifeport,investigational,FC1=CC=CN=C1CNC(=O)C1=COC(CCNCCC2=NC3=CC=CC=C3N2)=N1,C21H21FN6O2,1,"Heterocyclic Compounds, Fused-Ring",
DB13802,Epomediol,experimental,CC1(C)O[C@@]2(C)[C@@H](O)C[C@@H]1C[C@H]2O,C10H18O3,1,"Alimentary Tract and Metabolism, Bile and Liver Therapy, Cholagogues and Choleretics, Gastrointestinal Agents, Liver Therapy, Liver Therapy, Lipotropics",
DB13805,Reposal,experimental,CCC1(C(=O)NC(=O)NC1=O)C1=CC2CCC(C2)C1,C14H18N2O3,1,"Amines, Barbiturates, Plain, Benzene Derivatives, Central Nervous System Depressants, Enzyme Inhibitors, Hydroxy Acids, Hydroxylamines, Hypnotics and Sedatives, Nervous System, Psycholeptics",
DB00180,Flunisolide,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,C24H31FO6,1,"Adrenal Cortex Hormones, Adrenals, Agents to Treat Airway Disease, Anti-Asthmatic Agents, Anti-Inflammatory Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids for Systemic Use, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Fused-Ring Compounds, Immunosuppressive Agents, Nasal Preparations, Pregnadienes, Pregnanes, Respiratory System Agents, Steroids, Steroids, Fluorinated"," Glucocorticoid receptor,  Cytochrome P450 3A4,  Corticosteroid-binding globulin"
DB00187,Esmolol,approved; withdrawn,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,C16H25NO4,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Hypotensive Agents, Neurotransmitter Agents, Potential QTc-Prolonging Agents, Propanols, QTc Prolonging Agents"," Beta-1 adrenergic receptor,  Cytochrome P450 2D6"
DB13827,Indanazoline,experimental,C1CC2=C(C1)C(NC1=NCCN1)=CC=C2,C12H15N3,1,"Nasal Preparations, Sympathomimetics, Plain",
DB17818,Dextran 1,investigational,,,1,"Biopolymers, Carbohydrates, Glucans, Macromolecular Substances, Polymers, Polysaccharides",
DB00191,Phentermine,approved; illicit,CC(C)(N)CC1=CC=CC=C1,C10H15N,1,"Adrenergic Agents, Agents producing tachycardia, Agents that produce hypertension, Alimentary Tract and Metabolism, Amines, Amphetamines, Anti-Obesity Agents, Antiobesity Preparations, Excl. Diet Products, Appetite Depressants, Appetite Suppression, Autonomic Agents, Central Nervous System Agents, Centrally Acting Antiobesity Products, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Increased Sympathetic Activity, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Neurotransmitter Agents, Peripheral Nervous System Agents, Phenethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetic Amine Anorectic, Sympathomimetics"," Sodium-dependent noradrenaline transporter,  Sodium-dependent serotonin transporter,  Sodium-dependent dopamine transporter,  Amine oxidase [flavin-containing] A,  Amine oxidase [flavin-containing] B,  Pro-neuropeptide Y,  Cytochrome P450 3A4"
DB00193,Tramadol,approved; investigational,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,C16H25NO2,1,"Agents producing tachycardia, Agents that reduce seizure threshold, Alcohols, Amines, Analgesics, Anticholinergic Agents, Antidepressive Agents, Central Nervous System Agents, Central Nervous System Depressants, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Cyclohexanes, Cyclohexanols, Cycloparaffins, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Dimethylamines, Drugs that are Mainly Renally Excreted, Muscarinic Antagonists, Narcotics, Nervous System, NMDA Receptor Antagonists, Opiate Agonists, Opioid Agonist, Opioids, Peripheral Nervous System Agents, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 5-HT2 Receptor Antagonists, Serotonin 5-HT2C Receptor Antagonists, Serotonin Agents, Serotonin Modulators, Serotonin Receptor Antagonists, UGT1A1 Substrates"," Mu-type opioid receptor,  Sodium-dependent noradrenaline transporter,  Sodium-dependent serotonin transporter,  Sodium channel protein type 2 subunit alpha,  NMDA receptor (Protein Group),  Adenosine receptor A1,  Alpha-2 adrenergic receptors (Protein Group),  5-hydroxytryptamine receptor 2C,  Kappa-type opioid receptor, 10. Delta-type opioid receptor, 11. Neuronal acetylcholine receptor subunit alpha-7, 12. Muscarinic acetylcholine receptor M3, 13. Muscarinic acetylcholine receptor M1, 14. Neurokinin 1 receptor, 15. Transient receptor potential cation channel subfamily V member 1,  Cytochrome P450 2B6,  UDP-glucuronosyltransferase 1-1,  Cytochrome P450 2D6,  Cytochrome P450 3A4"
DB11429,Mibolerone,vet_approved,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],C20H30O2,1,"Estranes, Estrenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone and derivatives, Testosterone Congeners", Androgen receptor
DB00195,Betaxolol,approved; investigational,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,C18H29NO3,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antiglaucoma Preparations and Miotics, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Autonomic Agents, Beta Blocking Agents, Selective, Beta-adrenergic Agents, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Hypotensive Agents, Neurotransmitter Agents, Ophthalmologicals, Peripheral Nervous System Agents, Phenoxypropanolamines, Propanolamines, Propanols, QTc Prolonging Agents, Sensory Organs, Sympatholytics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Cytochrome P450 2D6,  Cytochrome P450 1A2"
DB17882,Epitalon,investigational,C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O,C14H22N4O9,1,"Amino Acids, Peptides, and Proteins, Peptides",
DB13852,Mefenorex,experimental,CC(CC1=CC=CC=C1)NCCCCl,C12H18ClN,1,"Agents producing tachycardia, Agents that produce hypertension, Alimentary Tract and Metabolism, Amines, Antiobesity Preparations, Excl. Diet Products, Autonomic Agents, Centrally Acting Antiobesity Products, Ethylamines, Peripheral Nervous System Agents, Phenethylamines, Sympathomimetics",
DB00214,Torasemide,approved,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,C16H20N4O3S,1,"Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Cardiovascular Agents, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Diuretics, High-Ceiling Diuretics, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis at Loop of Henle, Membrane Transport Modulators, Natriuretic Agents, Non Potassium Sparing Diuretics, OATP1B1/SLCO1B1 Substrates, Ototoxic agents, Pyridines, Sodium Potassium Chloride Symporter Inhibitors, Sulfonamides, Sulfones, Sulfur Compounds"," Solute carrier family 12 member 2,  Solute carrier family 12 member 1,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Serum albumin,  Solute carrier organic anion transporter family member 1B1"
DB02404,1-Deoxy-1-Thio-Heptaethylene Glycol,experimental,OCCOCCOCCOCCOCCOCCOCCS,C14H30O7S,1,, Acetylcholinesterase
DB11466,Tepoxalin,vet_approved,COC1=CC=C(C=C1)N1N=C(CCC(=O)N(C)O)C=C1C1=CC=C(Cl)C=C1,C20H20ClN3O3,1,"Agents causing hyperkalemia, Agents that produce hypertension, Analgesics, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Immunologic Factors, Immunosuppressive Agents, Nephrotoxic agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Sensory System Agents",
DB13867,Fluticasone,approved; experimental,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C22H27F3O4S,1,"Adrenal Cortex Hormones, Androstadienes, Androstanes, Androstenes, Anti-Allergic Agents, Anti-Asthmatic Agents, Anti-Inflammatory Agents, Autonomic Agents, Bronchodilator Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dermatologicals, Drugs for Obstructive Airway Diseases, Fused-Ring Compounds, Glucocorticoids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Nasal Preparations, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, Peripheral Nervous System Agents, Respiratory System Agents, Steroids, Thyroxine-binding globulin inhibitors"," Glucocorticoid receptor,  Progesterone receptor,  Cytosolic phospholipase A2,  Mineralocorticoid receptor,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C8,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1B1,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1B1"
DB11478,Zeranol,experimental; vet_approved,C[C@H]1CCC[C@H](O)CCCCCC2=CC(O)=CC(O)=C2C(=O)O1,C18H26O5,1,"Benzene Derivatives, Estrogens, Estrogens, Non-Steroidal, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Lactones, Phenols, Resorcinols, Zearalenone"," Estrogen receptor alpha,  Sex hormone-binding globulin"
DB11479,Zilpaterol,vet_approved,CC(C)N[C@@H]1CCN2C(=O)NC3=CC=CC([C@H]1O)=C23,C14H19N3O2,1,"Heterocyclic Compounds, Fused-Ring, Organosilicon Compounds, Receptors, Adrenergic, beta",
DB11487,Dexamethasone isonicotinate,vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C3=CC=NC=C3)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C28H32FNO6,1,"Adrenal Cortex Hormones, Anti-Allergic Agents, Anti-Inflammatory Agents, Corticosteroids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids, Steroids, Fluorinated"," Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB13917,Deoxyepinephrine,experimental,CNCCC1=CC(O)=C(O)C=C1,C9H13NO2,1,"Agents that produce hypertension, Amines, Benzene Derivatives, Catecholamines, Catechols, Epinephrine and similars, Phenols",
DB13929,Relcovaptan,investigational,COC1=CC=C(C=C1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(C2=CC(Cl)=CC=C12)C1=CC=CC=C1Cl,C28H27Cl2N3O7S,1,"Antiplatelet agents, Hematologic Agents, Heterocyclic Compounds, Fused-Ring, Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists"," Oxytocin receptor,  Vasopressin V1a receptor"
DB11510,Deslorelin,investigational; vet_approved,[H][C@]1(CCC(=O)N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC,C64H83N17O12,1,"Adrenal Cortex Hormones, Alcohol Dehydrogenase, antagonists & inhibitors, Amino Acids, Peptides, and Proteins, Enzyme Inhibitors, Gonadotropin-releasing hormone agonist, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hypothalamic Hormones, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Pituitary Hormone-Releasing Hormones, Proteins",
DB00264,Metoprolol,approved; investigational,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,C15H25NO3,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Beta blocking agents and calcium channel blockers, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Selective, Beta Blocking Agents, Selective, and Thiazides, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs causing inadvertant photosensitivity, Drugs that are Mainly Renally Excreted, Hypotensive Agents, OCT2 Inhibitors, Photosensitizing Agents, Propanolamines"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Beta adrenergic receptor (Protein Group),  Cytochrome P450 3A4,  Cytochrome P450 2D6,  Serum albumin,  Solute carrier family 22 member 2"
DB13943,Testosterone cypionate,approved,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C27H40O3,1,"Anabolic Agents, Androgens, Androstanes, Androstenes, Androstenols, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Delayed-Action Preparations, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, OAT3/SLC22A8 Inducers, P-glycoprotein inhibitors, Steroids, Testosterone and derivatives, Testosterone Congeners, Thyroxine-binding globulin inhibitors"," Androgen receptor,  Estrogen receptor alpha,  Mineralocorticoid receptor,  Cytochrome P450 3A4,  Amine oxidase [flavin-containing] A,  Cholesterol side-chain cleavage enzyme, mitochondrial,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 1A1,  Cytochrome P450 2A13,  Cytochrome P450 2B6,  Cytochrome P450 2C19, 10. Cytochrome P450 2C8, 11. Cytochrome P450 2C9, 12. Cytochrome P450 3A43, 13. 3-oxo-5-alpha-steroid 4-dehydrogenase (Protein Group), 14. Cytochrome P450 19A1,  Serum albumin,  Sex hormone-binding globulin,  Solute carrier organic anion transporter family member 1A2,  Solute carrier family 22 member 8,  Solute carrier family 22 member 7,  P-glycoprotein 1,  Sodium/bile acid cotransporter,  Solute carrier family 22 member 3,  Solute carrier family 22 member 4,  ATP-binding cassette sub-family G member 2"
DB13944,Testosterone enanthate,approved,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C26H40O3,1,"Adrenal Cortex Hormones, Androgens, Androstanes, Androstenes, Androstenols, BCRP/ABCG2 Substrates, Contraceptive Agents, Male, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormonal Contraceptives for Systemic Use, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, OAT3/SLC22A8 Inducers, P-glycoprotein inhibitors, Steroids, Testosterone and derivatives, Testosterone Congeners, Thyroxine-binding globulin inhibitors"," Androgen receptor,  Estrogen receptor alpha,  Mineralocorticoid receptor,  Cytochrome P450 3A4,  Amine oxidase [flavin-containing] A,  Cholesterol side-chain cleavage enzyme, mitochondrial,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 1A1,  Cytochrome P450 2A13,  Cytochrome P450 2B6,  Cytochrome P450 2C19, 10. Cytochrome P450 2C8, 11. Cytochrome P450 2C9, 12. Cytochrome P450 3A43, 13. 3-oxo-5-alpha-steroid 4-dehydrogenase (Protein Group), 14. Cytochrome P450 19A1,  Serum albumin,  Sex hormone-binding globulin,  Solute carrier organic anion transporter family member 1A2,  Solute carrier family 22 member 8,  Solute carrier family 22 member 7,  P-glycoprotein 1,  Sodium/bile acid cotransporter,  Solute carrier family 22 member 3,  Solute carrier family 22 member 4,  ATP-binding cassette sub-family G member 2"
DB13946,Testosterone undecanoate,approved; investigational,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,C30H48O3,1,"Androgens, Androstanes, Androstenes, Androstenols, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, OAT3/SLC22A8 Inducers, OATP1B3 substrates, P-glycoprotein inhibitors, Steroids, Testosterone and derivatives, Testosterone Congeners, Thyroxine-binding globulin inhibitors"," Androgen receptor,  Cytochrome P450 3A4,  Amine oxidase [flavin-containing] A,  Cholesterol side-chain cleavage enzyme, mitochondrial,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 1A1,  Cytochrome P450 1B1,  Cytochrome P450 2A13,  Cytochrome P450 2B6, 10. Cytochrome P450 2C19, 11. Cytochrome P450 2C8, 12. Cytochrome P450 2C9, 13. Cytochrome P450 3A43, 14. 3-oxo-5-alpha-steroid 4-dehydrogenase (Protein Group), 15. Cytochrome P450 19A1,  Serum albumin,  Sex hormone-binding globulin,  Solute carrier organic anion transporter family member 1A2,  Solute carrier family 22 member 8,  Solute carrier family 22 member 7,  P-glycoprotein 1,  Sodium/bile acid cotransporter,  Solute carrier family 22 member 4,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 2,  Multidrug and toxin extrusion protein 1, 10. Solute carrier organic anion transporter family member 1B3"
DB13947,Testosterone enantate benzilic acid hydrazone,approved; experimental,[H]N(N=C1CC[C@@]2(C)C(CC[C@@]3([H])[C@]4([H])CC[C@H](OC(=O)CCCCCC)[C@@]4(C)CC[C@]23[H])=C1)C(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,C40H52N2O4,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone and derivatives, Testosterone Congeners",
DB11541,Ractopamine,vet_approved,CC(CCC1=CC=C(O)C=C1)NCC(O)C1=CC=C(O)C=C1,C18H23NO3,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Amines, Ethylamines, Growth Substances, Neurotransmitter Agents", Estrogen receptor alpha
DB13958,Trestolone acetate,experimental,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],C21H30O3,1,"Estranes, Estrenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone and derivatives, Testosterone Congeners",
DB11551,Trenbolone,vet_approved,[H][C@@]12CC[C@H](O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],C18H22O2,1,"Anabolic Agents, Estranes, Estrenes, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids",
DB18059,MBS-2320,investigational,C[C@]1(O)CC[C@@H](CC1)NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(Cl)C=C1C#N,C20H21ClN2O3S,1,,
DB00295,Morphine,approved; investigational,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,C17H19NO3,1,"Alkaloids, Analgesics, Anesthetics, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Heterocyclic Compounds, Fused-Ring, High-risk opioids, Hypotensive Agents, Narcotics, Natural Opium Alkaloids, Nervous System, Neuraxial Anesthetics, Opiate Agonists, Opiate Alkaloids, Opioid Agonist, Opioids, P-glycoprotein substrates, Peripheral Nervous System Agents, Phenanthrenes, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, UGT1A1 Substrates, UGT1A3 substrates, UGT2B7 substrates"," Mu-type opioid receptor,  Kappa-type opioid receptor,  Delta-type opioid receptor,  Lymphocyte antigen 96,  Cytochrome P450 2C8,  Cytochrome P450 3A4,  UDP-glucuronosyltransferase 2B7,  UDP-glucuronosyltransferase 1-1,  UDP-glucuronosyltransferase 1-8,  UDP-glucuronosyltransferase 2B15,  UDP-glucuronosyltransferase 2B4,  UDP-glucuronosyltransferase 1-3,  Serum albumin,  P-glycoprotein 1"
DB11609,Normethadone,approved; illicit,CCC(=O)C(CCN(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,C20H25NO,1,"Analgesics, Antitussive Agents, Central Nervous System Agents, Central Nervous System Depressants, Cough and Cold Preparations, Ketones, Narcotics, Opioids, Opium Alkaloids and Derivatives, Peripheral Nervous System Agents, Respiratory System Agents, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",
DB11610,Oxilofrine,approved,[H][C@@](C)(NC)[C@]([H])(O)C1=CC=C(O)C=C1,C10H15NO2,1,"Alcohols, Amines, Amino Alcohols, Antitussive Agents, Ethylamines, Phenethylamines, Propanolamines, Propanols",
DB00327,Hydromorphone,approved; illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,C17H19NO3,1,"Alkaloids, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, High-risk opioids, Morphinans, Morphine Derivatives, Narcotics, Natural Opium Alkaloids, Nervous System, Opiate Agonists, Opiate Alkaloids, Opioid Agonist, Opioids, Peripheral Nervous System Agents, Phenanthrenes, Semi-synthetic Opioids, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, UGT1A3 substrates, UGT2B7 substrates"," Mu-type opioid receptor,  Delta-type opioid receptor,  Kappa-type opioid receptor,  UDP-glucuronosyltransferase 1-3,  UDP-glucuronosyltransferase 2B7,  Cytochrome P450 2C9,  Serum albumin"
DB11619,Gestrinone,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],C21H24O2,1,"Adrenal Cortex Hormones, Antigonadotropins and Similar Agents, Contraceptive Agents, Female, Contraceptive Agents, Hormonal, Contraceptives, Oral, Contraceptives, Oral, Hormonal, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Hormonal Contraceptives for Systemic Use, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Norpregnanes, Norpregnatrienes, Norsteroids, Progestin Contraceptives, Progestins, Reproductive Control Agents, Sex Hormones and Modulators of the Genital System, Steroids"," Sex hormone-binding globulin,  Progesterone receptor,  Glucocorticoid receptor,  Androgen receptor,  Gonadotropin-releasing hormone receptor,  Estrogen receptor alpha,  Cytochrome P450 3A4"
DB00333,Methadone,approved,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,C21H27NO,1,"Analgesics, Anticholinergic Agents, Antidepressive Agents, Antitussive Agents, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Diphenylpropylamine Derivatives, Drugs that are Mainly Renally Excreted, Drugs Used in Addictive Disorders, Drugs Used in Opioid Dependence, High-risk opioids, Ketones, Moderate Risk QTc-Prolonging Agents, Narcotics, Nervous System, Nicotinic Antagonists, NMDA Receptor Antagonists, Opiate Agonists, Opioid Agonist, Opioids, P-glycoprotein inhibitors, Peripheral Nervous System Agents, QTc Prolonging Agents, Respiratory System Agents, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents, Serotonin Modulators, Thyroxine-binding globulin inducers"," Mu-type opioid receptor,  NMDA receptor (Protein Group),  Delta-type opioid receptor,  Neuronal acetylcholine receptor subunit alpha-7,  5-hydroxytryptamine receptor 3A,  Neuronal acetylcholine receptor subunit alpha-3,  Neuronal acetylcholine receptor subunit alpha-4,  Neuronal acetylcholine receptor subunit beta-2,  Cytochrome P450 3A4,  Cytochrome P450 2C19,  Cytochrome P450 3A7,  Cytochrome P450 2D6,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 19A1,  Cytochrome P450 1A2,  Cytochrome P450 2C18, 10. Cytochrome P450 2C9, 11. Cytochrome P450 3A Subfamily (Protein Group), 12. UDP-glucuronosyltransferase 2B4,  Alpha-1-acid glycoprotein 1,  Serum albumin,  P-glycoprotein 1"
DB00335,Atenolol,approved,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,C14H22N2O3,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Autonomic Agents, Beta blocking agents and calcium channel blockers, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Selective, Beta Blocking Agents, Selective, and Thiazides, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, BSEP/ABCB11 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Hypotensive Agents, Peripheral Nervous System Agents, QTc shortening agents, Sympatholytics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Cytochrome P450 2D6,  Serum albumin,  Bile salt export pump"
DB04733,"1,6-DI-O-PHOSPHONO-D-MANNITOL",experimental,O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O,C6H16O12P2,1,, Fructose-bisphosphate aldolase A
DB00357,Aminoglutethimide,approved; investigational,CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1,C13H16N2O2,1,"Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, Aromatase Inhibitors, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Endocrine Therapy, Enzyme Inhibitors, Estrogen Antagonists, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Narrow Therapeutic Index Drugs, Piperidines, Piperidones, Steroid Synthesis Inhibitors"," Cholesterol side-chain cleavage enzyme, mitochondrial,  Cytochrome P450 19A1,  Cytochrome P450 3A4,  Cytochrome P450 2C19"
DB00368,Norepinephrine,approved,NC[C@H](O)C1=CC(O)=C(O)C=C1,C8H11NO3,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic and Dopaminergic Agents, Adrenergic beta-1 Receptor Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-3 Receptor Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Alpha-and Beta-adrenergic Agonists, Amines, Amino Alcohols, Autonomic Agents, Benzene Derivatives, Biogenic Amines, Biogenic Monoamines, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy, Cardiovascular Agents, Catecholamines, Catechols, COMT Substrates, Epinephrine and similars, Ethanolamines, Neurotransmitter Agents, Norepinephrine, antagonists & inhibitors, OCT1 substrates, OCT2 Inhibitors, OCT2 Substrates, Peripheral Nervous System Agents, Phenols, Sympathomimetics, Vasoconstrictor Agents"," Alpha-1A adrenergic receptor,  Alpha-1B adrenergic receptor,  Alpha-1D adrenergic receptor,  Alpha-2A adrenergic receptor,  Alpha-2B adrenergic receptor,  Alpha-2C adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Beta-3 adrenergic receptor, 10. Phenylalanine-4-hydroxylase, 11. Synaptic vesicular amine transporter, 12. Chromaffin granule amine transporter,  Sodium-dependent noradrenaline transporter,  Solute carrier family 22 member 2,  Solute carrier family 22 member 3,  Solute carrier family 22 member 5,  Solute carrier family 22 member 1,  POU domain, class 5, transcription factor 1"
DB00373,Timolol,approved,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,C13H24N4O3S,1,"Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antiglaucoma Preparations and Miotics, Antihypertensive Agents, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Beta Blocking Agents, Non-Selective, and Thiazides, Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, EENT Drugs, Miscellaneous, Hypotensive Agents, Morpholines, Ophthalmologicals, Oxazines, P-glycoprotein substrates, Potential QTc-Prolonging Agents, Propanolamines, Propanols, QTc Prolonging Agents, Sulfur Compounds, Thiadiazoles, Thiazoles"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Lysozyme,  Cytochrome P450 2C19,  Cytochrome P450 2D6,  P-glycoprotein 1"
DB11682,Daprodustat,approved; investigational,OC(=O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,C19H27N3O6,1,"Amino Acids, Amino Acids, Peptides, and Proteins, Antianemic Preparations, BCRP/ABCG2 Substrates, Blood and Blood Forming Organs, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor, Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors, OAT1/SLC22A6 Substrates, OAT3/SLC22A8 Substrates, OATP1B1/SLCO1B1 Inhibitors, OATP1B3 inhibitors, Pyrimidines, Pyrimidinones"," Egl nine homolog 1,  Egl nine homolog 2,  Egl nine homolog 3,  Cytochrome P450 2C8,  Cytochrome P450 3A4,  Solute carrier organic anion transporter family member 1B1,  Solute carrier organic anion transporter family member 1B3,  Solute carrier family 22 member 6,  Solute carrier family 22 member 8,  ATP-binding cassette sub-family G member 2"
DB18214,Ibutamoren,investigational,CC(C)(N)C(=O)N[C@H](COCC1=CC=CC=C1)C(=O)N1CCC2(CN(C3=CC=CC=C23)S(C)(=O)=O)CC1,C27H36N4O5S,1,"Heterocyclic Compounds, Fused-Ring",
DB00384,Triamterene,approved,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1,C12H11N7,1,"Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 Substrates, Decreased Renal K+ Excretion, Diuretics, Drugs causing inadvertant photosensitivity, Epithelial Sodium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Hypotensive Agents, Increased Diuresis, Membrane Transport Modulators, Natriuretic Agents, Nephrotoxic agents, Photosensitizing Agents, Potassium-Sparing Diuretics, Pteridines, Sodium Channel Blockers"," Amiloride-sensitive sodium channel subunit gamma,  Amiloride-sensitive sodium channel subunit alpha,  Amiloride-sensitive sodium channel subunit beta,  Amiloride-sensitive sodium channel subunit delta,  Cytochrome P450 1A2"
DB14093,"(1,2,6,7-3H)Testosterone",experimental,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C([3H])C([3H])C2=CC(=O)C([3H])C([3H])[C@]12C,C19H28O2,1,Testosterone and derivatives,
DB18246,Rencofilstat,investigational,[H][C@@]1([C@H](O)[C@H](C)CCCCCCNC(C)=O)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](CC)NC1=O)C(C)C,C67H122N12O13,1,"Amino Acids, Peptides, and Proteins, Peptides, Peptides, Cyclic",
DB14110,Butylene glycol,approved; experimental,CC(O)CCO,C4H10O2,1,"Alcohols, Glycols",
DB00421,Spironolactone,approved,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,C24H32O4S,1,"Agents causing hyperkalemia, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, BSEP/ABCB11 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 Enzyme Inhibitors, Diuretics, Fused-Ring Compounds, Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Hypotensive Agents, Lactones, Mineralocorticoid (Aldosterone) Receptor Antagonists, Mineralocorticoid Receptor Antagonists, Natriuretic Agents, P-glycoprotein inducers, Potassium-Sparing Diuretics, Pregnanes, Pregnenes, Steroids"," Mineralocorticoid receptor,  Glucocorticoid receptor,  Androgen receptor,  Progesterone receptor,  Estrogen receptor (Protein Group),  Nuclear receptor subfamily 1 group I member 2,  Voltage-dependent L-type calcium channel (Protein Group),  Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 2C8,  Cytochrome P450 11B2, mitochondrial,  Serum albumin,  alpha1-acid glycoprotein (Protein Group),  Canalicular multispecific organic anion transporter 1,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  Bile salt export pump"
DB14136,(-)-menthol 1-propylene glycol carbonate,experimental,[H]C(C)(O)COC(=O)O[C@]1([H])C[C@]([H])(C)CC[C@@]1([H])C(C)C,C14H26O4,1,,
DB00422,Methylphenidate,approved; investigational,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,C14H19NO2,1,"Acids, Carbocyclic, Agents that produce hypertension, Agents that reduce seizure threshold, Central Nervous System Agents, Central Nervous System Stimulants, Central Nervous System Stimulation, Centrally Acting Sympathomimetics, Dopamine Agents, Dopamine Uptake Inhibitors, Heterocyclic Compounds, Fused-Ring, Membrane Transport Modulators, Methylphenidate and isomer, Nervous System, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Phenylacetates, Piperidines, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Respiratory and CNS Stimulants"," Sodium-dependent dopamine transporter,  5-hydroxytryptamine receptor 1A,  Sodium-dependent noradrenaline transporter,  Carboxylesterase"
DB14140,Dipropylene glycol,experimental,,,1,,
DB07768,Epitestosterone,experimental,[H][C@@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,C19H28O2,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners"," Aldo-keto reductase family 1 member C1,  Aldo-keto reductase family 1 member C2"
DB04825,Prenylamine,approved; withdrawn,CC(CC1=CC=CC=C1)NCCC(C1=CC=CC=C1)C1=CC=CC=C1,C24H27N,1,"Adrenergic Agents, Agents causing hyperkalemia, Amines, Antiarrhythmic agents, Bradycardia-Causing Agents, Calcium Channel Blockers, Calcium-Regulating Hormones and Agents, Calmodulin, antagonists & inhibitors, Cardiac Therapy, Cardiovascular Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Ethylamines, Hydroxy Acids, Membrane Transport Modulators, Moderate Risk QTc-Prolonging Agents, Neurotransmitter Agents, Phenethylamines, QTc Prolonging Agents, Vasodilating Agents, Vasodilators Used in Cardiac Diseases"," Calmodulin,  Myosin light chain kinase 2, skeletal/cardiac muscle,  Cytochrome P450 3A4"
DB00436,Bendroflumethiazide,approved,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,C15H14F3N3O4S2,1,"Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Benzothiadiazines, Bradycardia-Causing Agents, Cardiovascular Agents, Diuretics, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, Heterocyclic Compounds, Fused-Ring, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis, Low-Ceiling Diuretics and Potassium-Sparing Agents, Membrane Transport Modulators, Natriuretic Agents, Sodium Chloride Symporter Inhibitors, Sulfonamides, Sulfones, Sulfur Compounds, Thiazides"," Solute carrier family 12 member 3,  Calcium-activated potassium channel subunit alpha-1,  Carbonic anhydrase 1,  Carbonic anhydrase 2,  Carbonic anhydrase 4,  Thiopurine S-methyltransferase"
DB18409,Fobrepodacin,investigational,[H][C@@]1(CCCO1)C1=C2NC(NC(=O)NCC)=NC2=CC(=C1F)C1=CN=C(N=C1)C(C)(C)OP(O)(O)=O,C21H26FN6O6P,1,,
DB02645,"3,4-Epoxybutyl-Alpha-D-Glucopyranoside",experimental,[H][C@]1(CCO[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)CO1,C10H18O7,1,, Beta-amylase
DB00443,Betamethasone,approved; vet_approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C22H29FO5,1,"Adrenal Cortex Hormones, Adrenals, Agents Causing Muscle Toxicity, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Alimentary Tract and Metabolism, Anti-Inflammatory Agents, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids Acting Locally, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (weak), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Drugs for Obstructive Airway Diseases, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Intestinal Antiinflammatory Agents, Nasal Preparations, Ophthalmological and Otological Preparations, Ophthalmologicals, Otologicals, P-glycoprotein substrates, Pregnadienes, Pregnadienetriols, Pregnanes, Respiratory System Agents, Steroids, Steroids, Fluorinated, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Thyroxine-binding globulin inhibitors, Vasoprotectives"," Glucocorticoid receptor,  Cytochrome P450 19A1,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2A6,  Cytochrome P450 1B1,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Cytochrome P450 2C19, 10. Cytochrome P450 3A4,  Serum albumin,  Corticosteroid-binding globulin,  P-glycoprotein 1"
DB04846,Celiprolol,approved; investigational,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O,C20H33N3O4,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-3 Receptor Agonists, Adrenergic beta-Agonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amides, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Autonomic Agents, Benzene Derivatives, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Neurotransmitter Agents, Peripheral Nervous System Agents, Phenoxypropanolamines, Phenylurea Compounds, Potential QTc-Prolonging Agents, Propanolamines, Propanols, QTc Prolonging Agents, Sympathomimetics, Vasodilating Agents"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Beta-3 adrenergic receptor,  Alpha-2A adrenergic receptor,  Alpha-2B adrenergic receptor,  Alpha-2C adrenergic receptor,  Cytochrome P450 2D6"
DB04847,Roxadustat,approved; investigational,CC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2,C19H16N2O5,1,"Amino Acids, Amino Acids, Peptides, and Proteins, Antianemic Preparations, BCRP/ABCG2 Inhibitors, Blood and Blood Forming Organs, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 Substrates, Heterocyclic Compounds, Fused-Ring, Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors, OAT1/SLC22A6 Substrates, OAT3/SLC22A8 Substrates, OATP1B1/SLCO1B1 Inhibitors, UGT1A9 Substrates"," Egl nine homolog 1,  Egl nine homolog 2,  Egl nine homolog 3,  Cytochrome P450 2C8,  UDP-glucuronosyltransferase 1-9,  Serum albumin,  ATP-binding cassette sub-family G member 2,  Solute carrier organic anion transporter family member 1B1,  Solute carrier family 22 member 6,  Solute carrier family 22 member 8"
DB00460,Verteporfin,approved; investigational,COC(=O)CCC1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(CCC(O)=O)=C5C)C(C=C)=C4C)C2=CC=C([C@@H](C(=O)OC)[C@@]32C)C(=O)OC)=C1C,C41H42N4O8,1,"Antineovascularisation Agents, Dermatologicals, EENT Drugs, Miscellaneous, Heterocyclic Compounds, Fused-Ring, Ocular Vascular Disorder Agents, Ophthalmologicals, Photoabsorption, Photoenhancer, Photosensitizing Activity, Photosensitizing Agents, Porphyrins, Radiation-Sensitizing Agents, Sensory Organs",
DB04861,Nebivolol,approved; investigational,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,C22H25F2NO4,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic Antagonists, Adrenergic beta-1 Receptor Agonists, Adrenergic beta-Agonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Benzopyrans, Beta blocking agents and calcium channel blockers, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Selective, Beta Blocking Agents, Selective, and Thiazides, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Ethanolamines, Heterocyclic Compounds, Fused-Ring, Hypotensive Agents, Neurotransmitter Agents, Pyrans, Vasodilating Agents"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Beta-3 adrenergic receptor,  Cytochrome P450 3A4,  Cytochrome P450 2C19,  Cytochrome P450 2D6,  Serum albumin"
DB04862,Merimepodib,investigational,COC1=C(C=CC(NC(=O)NC2=CC=CC(CNC(=O)O[C@H]3CCOC3)=C2)=C1)C1=CN=CO1,C23H24N4O6,1,"Acids, Acyclic, Amides, Benzene Derivatives, IMP Dehydrogenase, antagonists & inhibitors", Inosine-5'-monophosphate dehydrogenase
DB00475,Chlordiazepoxide,approved; illicit; investigational,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,C16H14ClN3O,1,"Adjuvants, Anesthesia, Anti-Anxiety Agents, Benzazepines, Benzodiazepines and benzodiazepine derivatives, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Cytosine Nucleotides, GABA Agents, GABA Modulators, Heterocyclic Compounds, Fused-Ring, Hypnotics and Sedatives, Nervous System, Neurotransmitter Agents, Nucleic Acids, Nucleotides, and Nucleosides, Nucleotides, Psycholeptics, Psychotropic Drugs, Pyrimidine Nucleotides, Pyrimidines, Ribonucleotides, Tranquilizing Agents"," GABA(A) Receptor (Protein Group),  GABA(A) Receptor Benzodiazepine Binding Site (Protein Group),  Cytochrome P450 3A4"
DB14205,Cobaltous cation,experimental,[Co++],Co,1,,
DB14206,Cobalt chloride,approved; experimental,[Cl-].[Cl-].[Co++],Cl2Co,1,"Antimutagenic Agents, Compounds used in a research, industrial, or household setting, Elements, Metals, Metals, Heavy, Protective Agents, Transition Elements",
DB00481,Raloxifene,approved; investigational,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,C28H27NO4S,1,"BCRP/ABCG2 Substrates, Benzene Derivatives, Benzylidene Compounds, Bone Density Conservation Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strong), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Estrogen Agonist-antagonists, Estrogen Agonist/Antagonist, Estrogen Antagonists, Estrogen Receptor Modulators, Genito Urinary System and Sex Hormones, Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, OATP1B1/SLCO1B1 Substrates, OATP1B3 substrates, P-glycoprotein substrates, Selective Estrogen Receptor Modulators, Sex Hormones and Modulators of the Genital System, Stilbenes, UGT1A1 Substrates"," Estrogen receptor alpha,  Estrogen receptor beta,  Serpin B9,  Trefoil factor 1,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Aldehyde oxidase,  Cytochrome P450 19A1,  Cytochrome P450 3A4,  UDP-glucuronosyltransferase 1-1,  UDP-glucuronosyltransferase 1-10,  UDP-glucuronosyltransferase 1-8,  Serum albumin,  Alpha-1-acid glycoprotein 1,  Solute carrier organic anion transporter family member 1B1,  Solute carrier organic anion transporter family member 1B3,  P-glycoprotein 1,  ATP-binding cassette sub-family G member 2,  Canalicular multispecific organic anion transporter 1,  Canalicular multispecific organic anion transporter 2,  Multidrug resistance-associated protein 4"
DB00489,Sotalol,approved,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,C12H20N2O3S,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Autonomic Agents, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Beta Blocking Agents, Non-Selective, and Thiazides, Bradycardia-Causing Agents, Cardiac Rhythm Alteration, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Ethanolamines, Highest Risk QTc-Prolonging Agents, Hypotensive Agents, Narrow Therapeutic Index Drugs, Neurotransmitter Agents, Peripheral Nervous System Agents, QTc Prolonging Agents, Sympatholytics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Potassium voltage-gated channel subfamily H member 2,  Cytochrome P450 2D6"
DB00497,Oxycodone,approved; illicit; investigational,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,C18H21NO4,1,"Alkaloids, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Heterocyclic Compounds, Fused-Ring, Morphinans, Morphine Derivatives, Narcotics, Natural Opium Alkaloids, Nervous System, Opiate Agonists, Opiate Alkaloids, Opioid Agonist, Opioids, Peripheral Nervous System Agents, Phenanthrenes, Semi-synthetic Opioids, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"," Mu-type opioid receptor,  Kappa-type opioid receptor,  Delta-type opioid receptor,  Cytochrome P450 2D6,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Serum albumin,  alpha1-acid glycoprotein (Protein Group)"
DB04890,Bepotastine,approved,OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,C21H25ClN2O3,1,"Anti-Allergic Agents, Drugs that are Mainly Renally Excreted, Histamine Antagonists, Histamine H1 Antagonists, Mast Cell Stabilizers", Histamine H1 receptor
DB00502,Haloperidol,approved,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,C21H23ClFNO2,1,"Agents that reduce seizure threshold, Anti-Dyskinesia Agents, Antiemetics, Antipsychotic Agents, Antipsychotic Agents (First Generation [Typical]), Autonomic Agents, Butyrophenone Derivatives, Butyrophenones, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dopamine Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Drugs that are Mainly Renally Excreted, Gastrointestinal Agents, Hyperglycemia-Associated Agents, Ketones, Moderate Risk QTc-Prolonging Agents, Nervous System, Neurotoxic agents, Neurotransmitter Agents, NMDA Receptor Antagonists, P-glycoprotein inhibitors, P-glycoprotein substrates, Peripheral Nervous System Agents, Photosensitizing Agents, Psycholeptics, Psychotropic Drugs, QTc Prolonging Agents, Tranquilizing Agents, UGT1A9 Substrates"," 5-hydroxytryptamine receptor 2C,  Dopamine D2 receptor,  5-hydroxytryptamine receptor 2A,  Dopamine D3 receptor,  Melanin-concentrating hormone receptor 1,  Synaptic vesicular amine transporter,  Sigma non-opioid intracellular receptor 1,  Histamine H1 receptor,  Muscarinic acetylcholine receptor M3, 10. Alpha-1A adrenergic receptor, 11. Alpha-2A adrenergic receptor, 12. Alpha-2B adrenergic receptor, 13. Alpha-2C adrenergic receptor, 14. 5-hydroxytryptamine receptor 1A, 15. 5-hydroxytryptamine receptor 6, 16. 5-hydroxytryptamine receptor 7, 17. Glutamate receptor ionotropic, NMDA 2B, 18. Dopamine D1 receptor,  Carbonyl reductase [NADPH] 1,  UDP-glucuronosyltransferase 1-9,  Cytochrome P450 2C19,  Cytochrome P450 2C9,  Cytochrome P450 1A1,  Cytochrome P450 1A2,  Cytochrome P450 2D6,  Cytochrome P450 3A5,  Cytochrome P450 3A4, 10. Cytochrome P450 3A7,  P-glycoprotein 1"
DB11837,Osilodrostat,approved; investigational,FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12,C13H10FN3,1,"Antiadrenal Preparations, Anticorticosteroids, Cortisol Synthesis Inhibitors, Cytochrome P-450 CYP11B2, antagonists & inhibitors, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (weak), Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P450 11B1 Inhibitors, MATE 1 Inhibitors, MATE inhibitors, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Inhibitors, OATP1B1/SLCO1B1 Inhibitors, OCT1 inhibitors, OCT2 Inhibitors, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, UGT1A4 substrates, UGT2B7 substrates"," Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 11B2, mitochondrial,  Cytochrome P450 3A4,  Cytochrome P450 2B6,  Cytochrome P450 2D6,  UDP-glucuronosyltransferase 1-4,  UDP-glucuronosyltransferase 2B7,  UDP-glucuronosyltransferase 2B10,  Cytochrome P450 3A5,  Cytochrome P450 1A2,  Cytochrome P450 2C19, 10. Cytochrome P450 2E1,  Solute carrier organic anion transporter family member 1B1,  Solute carrier family 22 member 1,  Solute carrier family 22 member 2,  Solute carrier family 22 member 6,  Solute carrier family 22 member 8,  Multidrug and toxin extrusion protein 1"
DB02726,2-Phosphoglycolic Acid,experimental,OC(=O)COP(O)(O)=O,C2H5O6P,1,," 2-deoxyglucose-6-phosphate phosphatase,  Beta-enolase,  Pyruvate kinase PKLR,  Triosephosphate isomerase,  Glucosamine-6-phosphate deaminase 1,  6-phosphofructokinase,  Triosephosphate isomerase,  Pyruvate kinase PKM,  Triosephosphate isomerase, 10. Methylglyoxal synthase, 11. Gamma-enolase, 12. Triosephosphate isomerase, 13. Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitive"
DB00521,Carteolol,approved,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,C16H24N2O3,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antiglaucoma Preparations and Miotics, Antihypertensive Agents, Autonomic Agents, Beta Blocking Agents, Non-Selective, Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Heterocyclic Compounds, Fused-Ring, Hypotensive Agents, Negative Inotrope, Neurotransmitter Agents, Ophthalmologicals, Peripheral Nervous System Agents, Phenoxypropanolamines, Potential QTc-Prolonging Agents, Propanolamines, Propanols, QTc Prolonging Agents, Quinolines, Quinolones, Sensory Organs, Sympatholytics"," Beta-2 adrenergic receptor,  Beta-1 adrenergic receptor,  Cytochrome P450 2D6"
DB00524,Metolazone,approved,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,C16H16ClN3O3S,1,"Amides, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Cardiovascular Agents, Diuretics, Drugs that are Mainly Renally Excreted, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, Heterocyclic Compounds, Fused-Ring, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis, Low-Ceiling Diuretics and Potassium-Sparing Agents, Low-Ceiling Diuretics, Excl. Thiazides, Membrane Transport Modulators, Natriuretic Agents, Non Potassium Sparing Diuretics, Quinazolines, Quinazolinones, Sodium Chloride Symporter Inhibitors, Sulfonamides, Sulfones, Sulfur Compounds, Thiazide-like Diuretic", Solute carrier family 12 member 3
DB00526,Oxaliplatin,approved; investigational,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,C8H14N2O4Pt,1,"Antineoplastic Agents, Antineoplastic and Immunomodulating Agents, BCRP/ABCG2 Substrates, Coordination Complexes, Immunosuppressive Agents, Moderate Risk QTc-Prolonging Agents, Myelosuppressive Agents, Narrow Therapeutic Index Drugs, OCT2 Substrates, OCT2 Substrates with a Narrow Therapeutic Index, Platinum Compounds, QTc Prolonging Agents"," DNA,  Glutathione S-transferase theta-1,  Metallothionein-1A,  Metallothionein-2,  Myeloperoxidase,  Superoxide dismutase [Cu-Zn],  Glutathione S-transferase P,  Glutathione S-transferase Mu 1,  NAD(P)H dehydrogenase [quinone] 1,  Serum albumin,  Solute carrier family 22 member 2,  High affinity copper uptake protein 1,  Solute carrier family 22 member 3,  ATP-binding cassette sub-family G member 2,  Canalicular multispecific organic anion transporter 1,  Copper-transporting ATPase 2,  Copper-transporting ATPase 1"
DB04938,Ospemifene,approved; investigational,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,C24H23ClO2,1,"Benzene Derivatives, Benzylidene Compounds, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Estrogen Agonist-antagonists, Estrogen Agonist/Antagonist, Genito Urinary System and Sex Hormones, Selective Estrogen Receptor Modulators, Sex Hormones and Modulators of the Genital System, Stilbenes"," Estrogen receptor alpha,  Cytochrome P450 3A4,  Cytochrome P450 2C9,  Cytochrome P450 2C19,  Cytochrome P450 2B6,  Cytochrome P450 2D6"
DB14512,Mometasone furoate,approved; investigational; vet_approved,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C27H30Cl2O6,1,"Adrenal Cortex Hormones, Adrenals, Adrenergics, Inhalants, Anti-Allergic Agents, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dermatologicals, Drugs for Obstructive Airway Diseases, Fused-Ring Compounds, Glucocorticoids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Nasal Preparations, Pregnadienes, Steroids, Thyroxine-binding globulin inhibitors"," Glucocorticoid receptor,  Progesterone receptor,  Cytochrome P450 2C8,  Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB14514,Magnesium levulinate,nutraceutical,[Mg++].CC(=O)CCC([O-])=O.CC(=O)CCC([O-])=O,C10H14MgO6,1,"Alimentary Tract and Metabolism, Enzyme Inhibitors, Keto Acids, Magnesium Compounds, Metal cations, Metal divalent cations, Mineral Supplements", Sodium/potassium-transporting ATPase subunit alpha-1
DB00539,Toremifene,approved; investigational,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,C26H28ClNO,1,"Anti-Estrogens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, Benzene Derivatives, Benzylidene Compounds, Bone Density Conservation Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Endocrine Therapy, Estrogen Agonist/Antagonist, Estrogen Receptor Modulators, Highest Risk QTc-Prolonging Agents, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein inhibitors, P-glycoprotein substrates, QTc Prolonging Agents, Selective Estrogen Receptor Modulators, Stilbenes"," Estrogen receptor alpha,  Sex hormone-binding globulin,  Cytochrome P450 1A1,  Cytochrome P450 3A4,  P-glycoprotein 1"
DB04980,Lemuteporfin,investigational,COC(=O)C1C(=CC=C2\C3=C\C4=N\C(=C/C5=C(C)C(CCC(=O)OCCO)=C(N5)\C=C5/N=C(/C=C(\N3)C12C)C(C)=C5CCC(=O)OCCO)\C(C=C)=C4C)C(=O)OC,C44H48N4O10,1,"Alcohols, Biological Factors, Glycols, Heterocyclic Compounds, Fused-Ring, Pigments, Biological",
DB14538,Hydrocortisone aceponate,experimental; vet_approved,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C26H36O7,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Immunosuppressive Agents, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Annexin A1,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C8,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB14539,Hydrocortisone acetate,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C23H32O6,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Aerosols, Anti-Inflammatory Agents, Corticosteroids, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Immunosuppressive Agents, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Annexin A1,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 11B2, mitochondrial,  Cytochrome P450 2C8,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB14540,Hydrocortisone butyrate,approved; vet_approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C25H36O6,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Administration, Topical, Adrenal Cortex Hormones, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Immunosuppressive Agents, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Annexin A1,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 11B2, mitochondrial,  Cytochrome P450 2C8,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB14541,Hydrocortisone cypionate,approved; investigational; vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C29H42O6,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Corticosteroids, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Annexin A1,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C8,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB00564,Carbamazepine,approved; investigational,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,C15H12N2O,1,"Analgesics, Analgesics, Non-Narcotic, Anticonvulsants, Antimanic Agents, Carboxamide Derivatives, Cardiovascular Agents, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP1A2 Inducers (strong), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strong), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers (strong), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Decreased Central Nervous System Disorganized Electrical Activity, Dibenzazepines, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index, Enzyme Inducing Antiepileptic Drugs, Heterocyclic Compounds, Fused-Ring, Immunosuppressive Agents, Inducers of Drug Clearance, Membrane Transport Modulators, Miscellaneous Anticonvulsants, Mood Stabilizer, Myelosuppressive Agents, Narrow Therapeutic Index Drugs, P-glycoprotein inducers, P-glycoprotein substrates, Peripheral Nervous System Agents, Psychotropic Drugs, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sodium Channel Blockers, Thyroxine-binding globulin substrates, UGT1A1 Inducers, UGT1A6 inducer, UGT2B7 substrates, UGT2B7 Substrates with a Narrow Therapeutic Index"," Voltage-gated sodium channel alpha subunit (Protein Group),  Neuronal acetylcholine receptor subunit alpha-4,  Nuclear receptor subfamily 1 group I member 2,  Cytochrome P450 3A4,  Cytochrome P450 2C8,  Cytochrome P450 1A2,  Cytochrome P450 2C9,  Cytochrome P450 2C19,  Cytochrome P450 2B6,  Cytochrome P450 3A5,  UDP-glucuronosyltransferase 2B7,  UDP-glucuronosyltransferase 1-1, 10. UDP-glucuronosyltransferase 1-6, 11. UDP-glucuronosyltransferase 1-7,  P-glycoprotein 1,  RalA-binding protein 1,  Canalicular multispecific organic anion transporter 1"
DB14542,Hydrocortisone phosphate,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C21H31O8P,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Corticosteroids, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Annexin A1,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C8,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB14543,Hydrocortisone probutate,approved; vet_approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C28H40O7,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Immunosuppressive Agents, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Annexin A1,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 11B2, mitochondrial,  Cytochrome P450 2C8,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB14544,Hydrocortisone valerate,approved; vet_approved,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C26H38O6,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Immunosuppressive Agents, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Annexin A1,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 11B2, mitochondrial,  Cytochrome P450 2C8,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB14545,Hydrocortisone succinate,approved,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C25H34O8,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Adrenals, Anti-Inflammatory Agents, Corticosteroids, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Immunosuppressive Agents, Pregnanes, Pregnenediones, Pregnenes, Steroids"," Cytochrome P450 3A4,  Cytochrome P450 2C8,  Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 11B2, mitochondrial"
DB00571,Propranolol,approved; investigational,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,C16H21NO2,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Beta Blocking Agents, Non-Selective, and Thiazides, Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Hypotensive Agents, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Naphthalenes, Negative Inotrope, Neurotransmitter Agents, OCT2 Inhibitors, P-glycoprotein inhibitors, P-glycoprotein substrates, Phenoxypropanolamines, Propanolamines, Propanols, QTc Prolonging Agents, Vasodilating Agents"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Beta-3 adrenergic receptor,  5-hydroxytryptamine receptor 1A,  5-hydroxytryptamine receptor 1B,  Cytochrome P450 1A1,  Amine oxidase [flavin-containing] A,  Cytochrome P450 1A2,  Cytochrome P450 2D6,  Cytochrome P450 2C19,  Cytochrome P450 3A5,  Cytochrome P450 3A4,  Cytochrome P450 3A7,  Alpha-1-acid glycoprotein 1,  Serum albumin,  Solute carrier family 22 member 2,  P-glycoprotein 1"
DB00574,Fenfluramine,approved; illicit; investigational; withdrawn,CCNC(C)CC1=CC=CC(=C1)C(F)(F)F,C12H16F3N,1,"Alimentary Tract and Metabolism, Amines, Anticonvulsants, Antidepressive Agents, Antiobesity Preparations, Excl. Diet Products, Central Nervous System Depressants, Centrally Acting Antiobesity Products, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Ethylamines, Membrane Transport Modulators, Nervous System, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Phenethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 5-HT2 Receptor Agonists, Serotonin Agents, Serotonin Receptor Agonists, Stimulants"," Sodium-dependent serotonin transporter,  5-hydroxytryptamine receptor 1D,  5-hydroxytryptamine receptor 2C,  Sigma non-opioid intracellular receptor 1,  5-hydroxytryptamine receptor 2A,  5-hydroxytryptamine receptor 2B,  5-hydroxytryptamine receptor 1A,  Cytochrome P450 1A2,  Cytochrome P450 2B6,  Cytochrome P450 2C9,  Cytochrome P450 2C19,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 2D6"
DB11921,Deflazacort,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,C25H31NO6,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Glucocorticoids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Steroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"," Glucocorticoid receptor,  Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB14574,Cobalt,approved; experimental; withdrawn,[Co],Co,1,"Cell-mediated Immunity, Diet, Food, and Nutrition, Elements, Food, Increased Histamine Release, Metals, Metals, Heavy, Micronutrients, Physiological Phenomena, Standardized Chemical Allergen, Trace Elements, Transition Elements",
DB00588,Fluticasone propionate,approved,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C25H31F3O5S,1,"Adrenal Cortex Hormones, Adrenals, Agents to Treat Airway Disease, Androstadienes, Androstanes, Androstenes, Anti-Allergic Agents, Anti-Asthmatic Agents, Anti-Inflammatory Agents, Autonomic Agents, Bronchodilator Agents, Central Nervous System Depressants, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dermatologicals, Fused-Ring Compounds, Glucocorticoids, Immunosuppressive Agents, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, Peripheral Nervous System Agents, Respiratory System Agents, Steroids, Thyroxine-binding globulin inhibitors"," Glucocorticoid receptor,  Progesterone receptor,  Cytosolic phospholipase A2,  Mineralocorticoid receptor,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C8,  Cytochrome P450 3A4,  Solute carrier organic anion transporter family member 1B1,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1B1"
DB05039,Indacaterol,approved,CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,C24H28N2O3,1,"Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Heterocyclic Compounds, Fused-Ring, Indenes, Long-acting beta-adrenoceptor agonists, P-glycoprotein substrates, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Quinolines, Selective Beta 2-adrenergic Agonists, UGT1A1 Substrates"," Beta-2 adrenergic receptor,  Cytochrome P450 3A4,  UDP-glucuronosyltransferase 1-1,  P-glycoprotein 1"
DB00591,Fluocinolone acetonide,approved; investigational; vet_approved,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,C24H30F2O6,1,"Adrenal Cortex Hormones, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Anti-Inflammatory Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids, Dermatological Preparations, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Immunosuppressive Agents, Ophthalmologicals, Otologicals, Pregnadienes, Pregnanes, Steroids, Steroids, Fluorinated, Vasoprotectives"," Glucocorticoid receptor,  Annexin A1,  Annexin A2,  Annexin A3,  Annexin A4,  Annexin A5,  Phospholipase A2,  Cytochrome P450 3A4,  Corticosteroid-binding globulin"
DB00594,Amiloride,approved,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,C6H8ClN7O,1,"Acid Sensing Ion Channel Blockers, Agents causing hyperkalemia, Cardiovascular Agents, Decreased Renal K+ Excretion, Diuretics, Epithelial Sodium Channel Blockers, Hypotensive Agents, Increased Diuresis, Membrane Transport Modulators, Natriuretic Agents, OCT2 Inhibitors, Potassium-Sparing Diuretics, Pyrazines, Sodium Channel Blockers"," Amiloride-sensitive sodium channel subunit alpha,  Amiloride-sensitive sodium channel subunit beta,  Amiloride-sensitive sodium channel subunit gamma,  Amiloride-sensitive sodium channel subunit delta,  Amiloride-sensitive amine oxidase [copper-containing],  Acid-sensing ion channel 2,  Acid-sensing ion channel 1,  Sodium/hydrogen exchanger 1,  Urokinase-type plasminogen activator,  Amiloride-sensitive amine oxidase [copper-containing],  Amiloride-sensitive amine oxidase [copper-containing],  Solute carrier family 22 member 2,  Solute carrier family 22 member 4"
DB14589,Caprylyl glycol,experimental,CCCCCCC(O)CO,C8H18O2,1,"Alcohols, Fatty Alcohols, Lipids",
DB00598,Labetalol,approved,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,C19H24N2O3,1,"Adrenergic Agents, Adrenergic alpha-1 Receptor Antagonists, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Agents producing tachycardia, Alcohols, Alpha and Beta Blocking Agents, Alpha and Beta Blocking Agents and Thiazides, Amides, Amines, Amino Alcohols, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Autonomic Agents, Beta Blocking Agents and Thiazides, Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Ethanolamines, Hypotensive Agents, Negative Inotrope, Neurotransmitter Agents, Peripheral alpha-1 blockers, Peripheral Nervous System Agents, Salicylamides, Sympathomimetics, UGT1A1 Substrates, UGT1A9 Substrates, UGT2B7 substrates, Vasodilating Agents"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Alpha-1 adrenergic receptors (Protein Group),  Cytochrome P450 2D6,  Cytochrome P450 2C19,  UDP-glucuronosyltransferase 1-1,  UDP-glucuronosyltransferase 2B7,  UDP-glucuronosyltransferase 1-9,  Serum albumin,  alpha1-acid glycoprotein (Protein Group),  ATP-binding cassette sub-family B member 5"
DB14624,Nandrolone hydrogen sulfate,experimental; investigational,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OS(O)(=O)=O,C18H26O5S,1,,
DB14625,Meprednisone acetate,experimental,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,C24H30O6,1,,
DB14631,Prednisolone phosphate,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C21H29O8P,1,"Adrenal Cortex Hormones, Adrenals, Anti-Inflammatory Agents, Corticosteroids, Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, OAT3/SLC22A8 Substrates, P-glycoprotein inducers, P-glycoprotein substrates, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids"," Glucocorticoid receptor,  Annexin A1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A Subfamily (Protein Group),  Cytochrome P450 2A6,  Cytochrome P450 1B1,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Cytochrome P450 2C19, 10. Corticosteroid 11-beta-dehydrogenase isozyme 2, 11. Corticosteroid 11-beta-dehydrogenase isozyme 1,  Corticosteroid-binding globulin,  Serum albumin,  Solute carrier organic anion transporter family member 1A2,  P-glycoprotein 1,  Solute carrier family 22 member 8"
DB14632,Prednisolone tebutate,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C27H38O6,1,"Fused-Ring Compounds, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids",
DB14633,Prednisolone hemisuccinate,experimental,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C25H32O8,1,"Adrenal Cortex Hormones, Corticosteroids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids"," Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB00612,Bisoprolol,approved,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,C18H31NO4,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Autonomic Agents, Beta blocking agents and calcium channel blockers, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Selective, Beta Blocking Agents, Selective, and Thiazides, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Hypotensive Agents, Neurotransmitter Agents, P-glycoprotein inhibitors, P-glycoprotein substrates, Peripheral Nervous System Agents, Phenoxypropanolamines, Propanolamines, Propanols, Sympatholytics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Cytochrome P450 3A4,  P-glycoprotein 1"
DB14637,Fluprednisolone acetate,experimental,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,C23H29FO6,1,"Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates", Cytochrome P450 3A4
DB14639,Boldenone undecylenate,illicit; vet_approved,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C,C30H44O3,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids", Androgen receptor
DB00620,Triamcinolone,approved; vet_approved,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C21H27FO6,1,"Adrenal Cortex Hormones, Adrenals, Agents Causing Muscle Toxicity, Agents to Treat Airway Disease, Alimentary Tract and Metabolism, Anti-Inflammatory Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids for Local Oral Treatment, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Corticosteroids, Dermatological Preparations, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Inducers, Cytochrome P-450 CYP3A7 Inducers (strength unknown), Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Drugs for Obstructive Airway Diseases, Enzyme Inhibitors, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunologic Factors, Immunosuppressive Agents, Nasal Preparations, Ophthalmologicals, Pregnadienes, Pregnanes, Protein-Lysine 6-Oxidase, antagonists & inhibitors, Sensory Organs, Steroids, Steroids, Fluorinated, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Thyroxine-binding globulin inhibitors, Vasoprotectives"," Glucocorticoid receptor,  Cytochrome P450 3A4,  Prostaglandin G/H synthase 2,  Cholinesterase,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Corticosteroid-binding globulin,  Serum albumin"
DB00621,Oxandrolone,approved; investigational,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C,C19H30O3,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Androgens, Androstan Derivatives, Androstanes, Androstanols, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Thyroxine-binding globulin inhibitors"," Androgen receptor,  Cytochrome P450 2C9"
DB14643,Methylprednisolone aceponate,approved; vet_approved,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,C27H36O7,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Dermatologicals, Fused-Ring Compounds, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids",
DB00624,Testosterone,approved; investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C19H28O2,1,"3-Oxoandrosten (4) Derivatives, Anabolic Steroids, Androgens, Androgens and Estrogens, Androstanes, Androstenes, Androstenols, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, OAT3/SLC22A8 Inducers, OATP1B3 substrates, P-glycoprotein inhibitors, Sex Hormones and Modulators of the Genital System, Steroids, Testosterone and derivatives, Testosterone Congeners, Thyroxine-binding globulin inhibitors"," Androgen receptor,  Estrogen receptor alpha,  Mineralocorticoid receptor,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 3A43,  Cytochrome P450 19A1,  Amine oxidase [flavin-containing] A,  Cholesterol side-chain cleavage enzyme, mitochondrial,  Cytochrome P450 1A1,  Cytochrome P450 1B1, 10. Cytochrome P450 2A13, 11. Cytochrome P450 2B6, 12. Cytochrome P450 2C19, 13. Cytochrome P450 2C9, 14. Cytochrome P450 2C8,  Serum albumin,  Sex hormone-binding globulin,  Solute carrier family 22 member 8,  Solute carrier family 22 member 7,  Sodium/bile acid cotransporter,  ATP-binding cassette sub-family G member 2,  Solute carrier organic anion transporter family member 1B3"
DB14644,Methylprednisolone hemisuccinate,approved,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,C26H34O8,1,"Adrenal Cortex Hormones, Adrenals, Anti-Inflammatory Agents, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Corticosteroids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Neuroprotective Agents, Pregnadienes, Pregnadienetriols, Pregnanes, Protective Agents, Steroids"," Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB14646,Prednisone acetate,approved; experimental; investigational,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C23H28O6,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Corticosteroids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienediols, Pregnadienes, Pregnanes, Steroids, Thyroxine-binding globulin inhibitors"," Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB14649,Dexamethasone acetate,approved; investigational; vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C24H31FO6,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, BCRP/ABCG2 Inhibitors, BSEP/ABCB11 inducers, Corticosteroids, Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (moderate), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Inducers, Cytochrome P-450 CYP3A7 Inducers (strength unknown), Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Fused-Ring Compounds, OAT3/SLC22A8 Substrates, P-glycoprotein inducers, P-glycoprotein inhibitors, P-glycoprotein substrates, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids, Steroids, Fluorinated"," Glucocorticoid receptor,  Annexin A1,  Nitric oxide synthase, inducible,  Nuclear receptor subfamily 0 group B member 1,  Nuclear receptor subfamily 1 group I member 2,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Steroid 17-alpha-hydroxylase/17,20 lyase,  Cytochrome P450 1A1,  Cytochrome P450 2A6,  Cytochrome P450 2B6,  Cytochrome P450 2C19,  Cytochrome P450 2C8, 10. Cytochrome P450 2E1, 11. Cytochrome P450 3A43, 12. Cytochrome P450 4A11, 13. Cytochrome P450 11B1, mitochondrial, 14. Corticosteroid 11-beta-dehydrogenase isozyme 2, 15. Corticosteroid 11-beta-dehydrogenase isozyme 1,  Serum albumin,  Bile salt export pump,  P-glycoprotein 1,  Canalicular multispecific organic anion transporter 1,  Solute carrier organic anion transporter family member 1A2,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8"
DB14655,Drostanolone propionate,approved; illicit,[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C,C23H36O3,1,"Androstanes, Fused-Ring Compounds, Steroids, Testosterone and derivatives",
DB00635,Prednisone,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C21H26O5,1,"Adrenal Cortex Hormones, Adrenals, Alimentary Tract and Metabolism, Anti-Inflammatory Agents, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids Acting Locally, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Intestinal Antiinflammatory Agents, P-glycoprotein inducers, P-glycoprotein inhibitors, P-glycoprotein substrates, Prednisolone and Prodrugs, Pregnadienediols, Pregnadienes, Pregnanes, Steroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Thyroxine-binding globulin inhibitors"," Glucocorticoid receptor,  Cytochrome P450 2C19,  Cytochrome P450 3A5,  Cytochrome P450 3A Subfamily (Protein Group),  Cytochrome P450 2A6,  Cytochrome P450 1B1,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Corticosteroid 11-beta-dehydrogenase isozyme 1, 10. Cytochrome P450 3A4,  Serum albumin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2"
DB05107,16-Bromoepiandrosterone,investigational,[H][C@@]12C[C@@H](Br)C(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C,C19H29BrO2,1,"17-Ketosteroids, Adrenal Cortex Hormones, Androstanes, Androstanols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Ketosteroids, Steroids, Testosterone Congeners", Glucose-6-phosphate 1-dehydrogenase
DB14660,Trenbolone acetate,vet_approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CCC4=C3C=C[C@]12C)OC(C)=O,C20H24O3,1,"Anabolic Agents, Estranes, Estrenes, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids",
DB14662,Flunisolide acetate,experimental,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C26H33FO7,1,"Anti-Asthmatic Agents, Anti-Inflammatory Agents, Fused-Ring Compounds, Pregnadienes, Pregnanes, Respiratory System Agents, Steroids, Steroids, Fluorinated",
DB00644,Gonadorelin,approved; investigational; vet_approved,CC(C)CC(NC(=O)CNC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(N)=O,C55H75N17O13,1,"Adrenal Cortex Hormones, Amino Acids, Peptides, and Proteins, Diagnostic Agents, Gonadotropin-releasing hormone agonist, Gonadotropin-Releasing Hormone, agonists, Gonadotropin-Releasing Hormone, antagonists & inhibitors, Gonadotropins and Antigonadotropins, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hypothalamic Hormones, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Pituitary and Hypothalamic Hormones and Analogues, Pituitary Function, Pituitary Hormone-Releasing Hormones, Proteins, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Tests for Fertility Disturbances"," Gonadotropin-releasing hormone receptor,  Putative gonadotropin-releasing hormone II receptor"
DB14664,Difluocortolone pivalate,experimental,[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C27H36F2O5,1,,
DB14669,Betamethasone phosphate,approved; vet_approved,[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C22H30FO8P,1,"Adrenal Cortex Hormones, Corticosteroids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, OAT3/SLC22A8 Substrates, P-glycoprotein inducers, P-glycoprotein substrates, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids, Steroids, Fluorinated"," Glucocorticoid receptor,  Annexin A1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Corticosteroid-binding globulin,  Serum albumin,  Solute carrier organic anion transporter family member 1A2,  P-glycoprotein 1,  Solute carrier family 22 member 8"
DB00652,Pentazocine,approved; vet_approved,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,C19H27NO,1,"Adjuvants, Anesthesia, Agents that reduce seizure threshold, Alkaloids, Analgesics, Benzomorphan Derivatives, Benzomorphans, Central Nervous System Agents, Central Nervous System Depressants, Heterocyclic Compounds, Fused-Ring, Mixed Agonist / Antagonist Opioids, Morphinans, Narcotics, Nervous System, Opiate Alkaloids, Opiate Partial Agonists, Opioid Antagonists, Opioids, P-glycoprotein substrates, Partial Opioid Agonist/Antagonist, Peripheral Nervous System Agents, Phenanthrenes, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"," Sigma non-opioid intracellular receptor 1,  Mu-type opioid receptor,  Kappa-type opioid receptor,  P-glycoprotein 1"
DB14681,Cortisone,experimental,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C21H28O5,1,"17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydroxycorticosteroids, Ophthalmologicals, Pregnanes, Pregnenes, Sensory Organs, Steroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"," Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB00666,Nafarelin,approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,C66H83N17O13,1,"Adrenal Cortex Hormones, Agents Causing Muscle Toxicity, Amino Acids, Peptides, and Proteins, Fertility Agents, Fertility Agents, Female, Gonadotropin Releasing Hormone Receptor Agonist, Gonadotropin Releasing Hormone Receptor Agonists, Gonadotropin-releasing hormone agonist, Gonadotropins and Antigonadotropins, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hypothalamic Hormones, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Pituitary and Hypothalamic Hormones and Analogues, Pituitary Hormone-Releasing Hormones, Proteins, Reproductive Control Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"," Gonadotropin-releasing hormone receptor,  Putative gonadotropin-releasing hormone II receptor"
DB00668,Epinephrine,approved; vet_approved,CNC[C@H](O)C1=CC(O)=C(O)C=C1,C9H13NO3,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic and Dopaminergic Agents, Adrenergic beta-1 Receptor Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-3 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Alpha-and Beta-adrenergic Agonists, Amines, Anti-Asthmatic Agents, Antiglaucoma Preparations and Miotics, Autonomic Agents, Benzene Derivatives, Biogenic Amines, Biogenic Monoamines, Bronchodilator Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy, Cardiovascular Agents, Catecholamines, Catechols, COMT Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Dental Agents, Drugs for Obstructive Airway Diseases, Epinephrine and similars, Hemostatics, Hyperglycemia-Associated Agents, Local Hemostatics, Mydriatics, Nasal Preparations, Neurotransmitter Agents, OCT1 substrates, OCT2 Inhibitors, OCT2 Substrates, Ophthalmologicals, Peripheral Nervous System Agents, Phenols, Respiratory System Agents, Stomatological Preparations, Sympathomimetic (Adrenergic) Agents, Sympathomimetics, Sympathomimetics in Glaucoma Therapy, Sympathomimetics, Plain, Vasoconstrictor Agents"," Alpha-1A adrenergic receptor,  Alpha-1B adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Alpha-2A adrenergic receptor,  Alpha-2B adrenergic receptor,  Alpha-1D adrenergic receptor,  Tumor necrosis factor,  Cytochrome P450 2C9,  Cytochrome P450 3A4,  Catechol O-methyltransferase,  Monoamine oxidase (Protein Group),  Solute carrier family 22 member 2,  Solute carrier family 22 member 1"
DB14703,Dexamethasone metasulfobenzoate,approved; experimental,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C3=CC=CC(=C3)S(O)(=O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C29H33FO9S,1,"Adrenal Cortex Hormones, Corticosteroids, Fused-Ring Compounds, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids, Steroids, Fluorinated",
DB00675,Tamoxifen,approved,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,C26H29NO,1,"Anti-Estrogens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, BCRP/ABCG2 Substrates, Benzene Derivatives, Benzylidene Compounds, BSEP/ABCB11 Inhibitors, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (moderate), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Endocrine Therapy, Estrogen Agonist/Antagonist, Estrogen Antagonists, Estrogen Receptor Modulators, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Narrow Therapeutic Index Drugs, P-glycoprotein inducers, P-glycoprotein inhibitors, P-glycoprotein substrates, P-glycoprotein substrates with a Narrow Therapeutic Index, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Selective Estrogen Receptor Modulators, Stilbenes, Thyroxine-binding globulin inducers, UGT2B17 substrates, UGT2B7 substrates, UGT2B7 Substrates with a Narrow Therapeutic Index"," Estrogen receptor alpha,  Estrogen receptor beta,  Protein kinase C (Protein Group),  Sex hormone-binding globulin,  3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase,  Androgen receptor,  Potassium voltage-gated channel subfamily H member 2,  Nuclear receptor subfamily 1 group I member 2,  Estrogen-related receptor gamma, 10. Mitogen-activated protein kinase 8,  Cytochrome P450 2D6,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C9,  Cytochrome P450 2C19,  Cytochrome P450 2B6,  Cytochrome P450 1A1,  Cytochrome P450 1B1, 10. Dimethylaniline monooxygenase [N-oxide-forming] 1, 11. Dimethylaniline monooxygenase [N-oxide-forming] 3, 12. Cytochrome P450 2C8, 13. Liver carboxylesterase 1, 14. Cytochrome P450 19A1, 15. Cytochrome P450 2A6, 16. Cytochrome P450 2E1, 17. UDP-glucuronosyltransferase 1-10, 18. Sulfotransferase 1A1, 19. Bile salt sulfotransferase, 20. Cytochrome P450 1A2, 21. UDP-glucuronosyltransferase 2B7, 22. UDP-glucuronosyltransferase 2B17, 23. Estrogen sulfotransferase,  Serum albumin,  Thyroxine-binding globulin,  P-glycoprotein 1,  ATP-binding cassette sub-family G member 2,  Canalicular multispecific organic anion transporter 1,  Bile salt export pump,  ATP-binding cassette sub-family A member 1"
DB00687,Fludrocortisone,approved; investigational,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C21H29FO5,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Adrenals, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydroxycorticosteroids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Mineralocorticoids, Pregnenes, Steroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"," Mineralocorticoid receptor,  Glucocorticoid receptor,  Cytochrome P450 3A4,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  Corticosteroid 11-beta-dehydrogenase isozyme 1,  Serum albumin,  Corticosteroid-binding globulin"
DB00695,Furosemide,approved; vet_approved,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,C12H11ClN2O5S,1,"Acids, Carbocyclic, Amides, Amines, Aminobenzoates, Aniline Compounds, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Benzene Derivatives, Benzoates, Cardiovascular Agents, Diuretics, Drugs causing inadvertant photosensitivity, Drugs that are Mainly Renally Excreted, High-Ceiling Diuretics, High-Ceiling Diuretics and Potassium-Sparing Agents, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis at Loop of Henle, Membrane Transport Modulators, Natriuretic Agents, Nephrotoxic agents, Non Potassium Sparing Diuretics, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Inhibitors, Ototoxic agents, Photosensitizing Agents, Sodium Potassium Chloride Symporter Inhibitors, Sulfanilamides, Sulfonamides, Sulfones, Sulfur Compounds, Thyroxine-binding globulin substrates, UGT1A1 Substrates"," Solute carrier family 12 member 1,  Carbonic anhydrase 2,  G-protein coupled receptor 35,  6-phosphogluconate dehydrogenase, decarboxylating,  UDP-glucuronosyltransferase 1-1,  Serum albumin,  Thyroxine-binding globulin,  Solute carrier family 22 member 6,  Solute carrier family 22 member 5,  Solute carrier family 22 member 8,  Canalicular multispecific organic anion transporter 1,  Solute carrier organic anion transporter family member 2A1,  Solute carrier family 22 member 11"
DB14752,Racephedrine,approved; experimental,CN[C@H](C)[C@@H](O)C1=CC=CC=C1,C10H15NO,1,"Adrenergic Agonists, Adrenergic alpha-Agonists, Adrenergic beta-Agonists, Alpha-and Beta-adrenergic Agonists, Herbs and Natural Products, Norepinephrine Releasing Agents, Sympathomimetic (Adrenergic) Agents",
DB14754,Solriamfetol,approved,N[C@@H](COC(N)=O)CC1=CC=CC=C1,C10H14N2O2,1,"Acids, Acyclic, Adrenergic Agents, Adrenergic Uptake Inhibitors, Agents producing tachycardia, Agents that produce hypertension, Amino Acids, Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Peptides, and Proteins, Antidepressive Agents, Central Nervous System Agents, Central Nervous System Depressants, Centrally Acting Sympathomimetics, Dopamine Agents, Dopamine And Norepinephrine Reuptake Inhibitors, Dopamine Uptake Inhibitors, Drugs that are Mainly Renally Excreted, MATE 1 Substrates, MATE substrates, Nervous System, Norepinephrine Reuptake Inhibitor, OCT2 Substrates, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Wakefulness-Promoting Agents"," Sodium-dependent dopamine transporter,  Sodium-dependent noradrenaline transporter,  Solute carrier family 22 member 2,  Solute carrier family 22 member 4,  Solute carrier family 22 member 5"
DB02924,"(4R)-limonene 1α,2α-epoxide",experimental,CC(=C)[C@@H]1CC[C@@]2(C)O[C@H]2C1,C10H16O,1,, Epididymal-specific lipocalin-9
DB00714,Apomorphine,approved; investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23,C17H17NO2,1,"Alkaloids, Anti-Parkinson Agents (Dopamine Agonist), Anti-Parkinson Drugs, Antidepressive Agents, Aporphines, Autonomic Agents, Benzylisoquinolines, Central Nervous System Agents, Central Nervous System Depressants, COMT Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Dopamine Agents, Dopamine Agonists, Drugs Used in Erectile Dysfunction, Emetics, Gastrointestinal Agents, Genito Urinary System and Sex Hormones, Heterocyclic Compounds, Fused-Ring, Hypotensive Agents, Isoquinolines, Nervous System, Neurotransmitter Agents, Nonergot-derivative Dopamine Receptor Agonists, Opiate Agonists, Peripheral Nervous System Agents, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents, Serotonin Receptor Antagonists, Urologicals"," Dopamine D4 receptor,  Dopamine D2 receptor,  Dopamine D3 receptor,  Dopamine D5 receptor,  Dopamine D1 receptor,  Alpha-2C adrenergic receptor,  Alpha-2B adrenergic receptor,  5-hydroxytryptamine receptor 1A,  5-hydroxytryptamine receptor 2A, 10. 5-hydroxytryptamine receptor 2B, 11. 5-hydroxytryptamine receptor 2C, 12. Alpha-2A adrenergic receptor, 13. 5-hydroxytryptamine receptor 1D, 14. 5-hydroxytryptamine receptor 1B,  Catechol O-methyltransferase,  Sulfotransferase 1A1,  Sulfotransferase 1A2,  Sulfotransferase 1A3/1A4,  Estrogen sulfotransferase,  Sulfotransferase family cytosolic 1B member 1,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 3A4, 10. Cytochrome P450 3A5, 11. UDP-glucuronosyltransferases (UGTs) (Protein Group),  Serum albumin,  Synaptic vesicular amine transporter"
DB12078,Enobosarm,investigational,C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC1=CC=C(C#N)C(=C1)C(F)(F)F,C19H14F3N3O3,1,"Amides, Amines, Aniline Compounds",
DB12097,Mannitol busulfan,approved; investigational,CS(=O)(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)COS(C)(=O)=O,C8H18O10S2,1,Agents causing hyperkalemia,
DB00741,Hydrocortisone,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C21H30O5,1,"11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Adrenals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Alimentary Tract and Metabolism, Anti-Inflammatory Agents, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids Acting Locally, Corticosteroids for Local Oral Treatment, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Corticosteroids, Dermatological Preparations, Corticosteroids, Weak (Group I), Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydrocortisone and derivatives, Hydroxycorticosteroids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Intestinal Antiinflammatory Agents, Nasal Preparations, OAT3/SLC22A8 Substrates, Ophthalmological and Otological Preparations, Ophthalmologicals, Otologicals, P-glycoprotein inducers, P-glycoprotein substrates, Pregnanes, Pregnenediones, Pregnenes, Sensory Organs, Steroids, Stomatological Preparations, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Vasoprotectives"," Glucocorticoid receptor,  Annexin A1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 11B1, mitochondrial,  Cytochrome P450 11B2, mitochondrial,  Cytochrome P450 2C8,  3-oxo-5-beta-steroid 4-dehydrogenase,  3-oxo-5-alpha-steroid 4-dehydrogenase 2,  Corticosteroid 11-beta-dehydrogenase isozyme 2, 10. Corticosteroid 11-beta-dehydrogenase isozyme 1, 11. Cytochrome P450 2A6, 12. Cytochrome P450 1B1, 13. Cytochrome P450 2B6, 14. Cytochrome P450 2C9, 15. Cytochrome P450 2C19,  Sex hormone-binding globulin,  Corticosteroid-binding globulin,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  Solute carrier family 22 member 8"
DB00742,Mannitol,approved; investigational,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,C6H14O6,1,"Agents causing hyperkalemia, Alcohols, Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Blood Substitutes and Perfusion Solutions, Carbohydrates, Compounds used in a research, industrial, or household setting, Cough and Cold Preparations, Diagnostic Agents, Diet, Food, and Nutrition, Diuretics, Diuretics, Osmotic, Drugs for Constipation, Drugs that are Mainly Renally Excreted, Expectorants, Flavoring Agents, Food, Food Additives, Food Ingredients, Hypotensive Agents, i.v. Solutions, Increased Diuresis, Irrigating Solutions, Kidney Function, Laxatives, Natriuretic Agents, Nephrotoxic agents, Osmotic Activity, Osmotic Laxatives, P-glycoprotein substrates, Physiological Phenomena, Solutions Producing Osmotic Diuresis, Sugar Alcohols, Sweetening Agents", Mannitol dehydrogenase
DB00745,Modafinil,approved; investigational,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,C15H15NO2S,1,"Benzene Derivatives, Benzhydryl Compounds, Central Nervous System Agents, Central Nervous System Stimulants, Central Nervous System Stimulation, Centrally Acting Sympathomimetics, Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (moderate), Cytochrome P-450 CYP3A5 Inducers (weak), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Increased Sympathetic Activity, Nervous System, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Stimulants, Sympathomimetic-like Agent, Wakefulness-Promoting Agents"," Sodium-dependent dopamine transporter,  Alpha-1B adrenergic receptor,  Cytochrome P450 2C19,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 1A2,  Cytochrome P450 2B6,  Cytochrome P450 2C9,  Cytochrome P450 2D6"
DB14823,Balovaptan,investigational,CN1CC2=NN=C([C@H]3CC[C@@H](CC3)OC3=NC=CC=C3)N2C2=CC=C(Cl)C=C2C1,C22H24ClN5O,1,"Antidiuretic Hormone Receptor Antagonists, Benzazepines, Heterocyclic Compounds, Fused-Ring, Natriuretic Agents",
DB00764,Mometasone,experimental,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C22H28Cl2O4,1,"Adrenal Cortex Hormones, Adrenals, Anti-Allergic Agents, Anti-Inflammatory Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dermatologicals, Drugs for Obstructive Airway Diseases, Fused-Ring Compounds, Glucocorticoids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Nasal Preparations, Pregnadienediols, Pregnadienes, Pregnanes, Steroids, Thyroxine-binding globulin inhibitors"," Glucocorticoid receptor,  Progesterone receptor,  Cytochrome P450 2C8,  Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB12134,Gepotidacin,investigational,O=C1C=CC2=C3N1C[C@@H](CN1CCC(CC1)NCC1=CC4=C(OCCC4)C=N1)N3C(=O)C=N2,C24H28N6O3,1,"Antineoplastic Agents, Enzyme Inhibitors, Heterocyclic Compounds, Fused-Ring, Naphthalenes, Topoisomerase Inhibitors",
DB02998,Metribolone,experimental,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],C19H24O2,1,"Estranes, Estrenes, Fused-Ring Compounds, Steroids"," Androgen receptor,  Nuclear receptor coactivator 2,  Mineralocorticoid receptor,  Progesterone receptor,  Prostate-specific antigen"
DB03026,Phosphoglycolohydroxamic Acid,experimental,ONC(=O)COP(O)(O)=O,C2H6NO6P,1,," D-tagatose-1,6-bisphosphate aldolase subunit KbaY,  Fructose-bisphosphate aldolase class 2,  Triosephosphate isomerase,  Methylglyoxal synthase,  Rhamnulose-1-phosphate aldolase,  L-fuculose phosphate aldolase"
DB14923,Satavaptan,investigational,CCOC1=CC=C2N(C(=O)[C@@]3(CC[C@@H](CC3)OCCN3CCOCC3)C2=C1)S(=O)(=O)C1=CC=C(C=C1OC)C(=O)NC(C)(C)C,C33H45N3O8S,1,"Antidiuretic Hormone Receptor Antagonists, Natriuretic Agents, Oxazines",
DB00808,Indapamide,approved,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,C16H16ClN3O3S,1,"Amides, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Cardiovascular Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Diuretics, Drugs causing inadvertant photosensitivity, Drugs that are Mainly Renally Excreted, Genito Urinary System and Sex Hormones, Heterocyclic Compounds, Fused-Ring, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis, Indoles, Lipid Modifying Agents, Low-Ceiling Diuretics, Excl. Thiazides, Membrane Transport Modulators, Natriuretic Agents, Non Potassium Sparing Diuretics, Photosensitizing Agents, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Sodium Chloride Symporter Inhibitors, Sulfonamides, Sulfones, Sulfur Compounds, Thiazide-like Diuretic"," Solute carrier family 12 member 3,  Cytochrome P450 3A4,  Epoxide hydrolase 1,  alpha1-acid glycoprotein (Protein Group),  Serum albumin"
DB00813,Fentanyl,approved; illicit; investigational; vet_approved,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,C22H28N2O,1,"Adjuvants, Adjuvants, Anesthesia, Agents that produce hypertension, Agents that reduce seizure threshold, Analgesics, Anesthetics, Anesthetics, General, Anesthetics, Intravenous, Antidepressive Agents, Bradycardia-Causing Agents, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Fentanyl and fentanyl analogues, High-risk opioids, Narcotics, Nervous System, Neuraxial Anesthetics, Opiate Agonists, Opioid Agonist, Opioid Anesthetics, Opioids, Opioids, Anilidopiperidine, P-glycoprotein inhibitors, Peripheral Nervous System Agents, Phenylpiperidine opioids, Piperidines, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents, Serotonin Modulators"," Mu-type opioid receptor,  Delta-type opioid receptor,  Kappa-type opioid receptor,  P-glycoprotein 1,  Cytochrome P450 3A4,  Cytochrome P450 3A7,  Serum albumin,  alpha1-acid glycoprotein (Protein Group),  P-glycoprotein 1"
DB05394,Corticorelin,investigational,,,1,"Amino Acids, Peptides, and Proteins, Corticotropin-Releasing Hormone, Diagnostic Agents, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hypothalamic Hormones, Nerve Tissue Proteins, Neuropeptides, Peptide Hormones, Peptides, Pituitary Hormone-Releasing Hormones, Proteins, Tests for Pituitary Function", Dopamine beta-hydroxylase
DB00819,Acetazolamide,approved; vet_approved,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,C4H6N4O3S2,1,"Anticonvulsants, Antiglaucoma Agents, Antiglaucoma Preparations and Miotics, Carbonic Anhydrase Inhibitors, Cardiovascular Agents, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Diuretics, Drugs causing inadvertant photosensitivity, Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, Natriuretic Agents, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Photosensitizing Agents, Sensory Organs, Sulfonamides, Sulfur Compounds, Thiadiazoles, Thiazoles"," Carbonic anhydrase 1,  Carbonic anhydrase 2,  Carbonic anhydrase 4,  Carbonic anhydrase 12,  Carbonic anhydrase 14,  Carbonic anhydrase 3,  Carbonic anhydrase 7,  Aquaporin-1,  Cytochrome P450 3A4,  Solute carrier family 22 member 6"
DB00830,Phenmetrazine,approved; illicit,CC1NCCOC1C1=CC=CC=C1,C11H15NO,1,"Agents producing tachycardia, Agents that produce hypertension, Anti-Obesity Agents, Appetite Depressants, Autonomic Agents, Central Nervous System Agents, Central Nervous System Stimulants, Morpholines, Oxazines, Peripheral Nervous System Agents, Sympathomimetics"," Sodium-dependent noradrenaline transporter,  Sodium-dependent dopamine transporter"
DB12221,Canrenone,investigational,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@]12C,C22H28O3,1,"Agents causing hyperkalemia, Diuretics, Fused-Ring Compounds, Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Mineralocorticoid Receptor Antagonists, Natriuretic Agents, Potassium-Sparing Diuretics, Pregnadienes, Pregnanes, Steroids",
DB00852,Pseudoephedrine,approved,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,C10H15NO,1,"Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Alpha-and Beta-adrenergic Agonists, Amines, Amino Alcohols, Amphetamines, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Cardiovascular Agents, Ethylamines, Hyperglycemia-Associated Agents, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Nasal Decongestants, Nasal Decongestants for Systemic Use, Nasal Preparations, Norepinephrine Releasing Agents, Peripheral Nervous System Agents, Phenethylamines, Propanolamines, Propanols, Respiratory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetic (Adrenergic) Agents, Sympathomimetics, Tumor Necrosis Factor Blockers, Vasoconstrictor Agents"," Sodium-dependent noradrenaline transporter,  Sodium-dependent dopamine transporter,  Alpha-1A adrenergic receptor,  Alpha-2A adrenergic receptor,  Sodium-dependent serotonin transporter,  Beta-2 adrenergic receptor,  Beta-1 adrenergic receptor,  Nuclear factor of activated T-cells, cytoplasmic 1,  Tumor necrosis factor, 10. Nuclear factor NF-kappa-B p105 subunit, 11. activator protein 1 (Protein Group), 12. Interleukin-2,  Amine oxidase [flavin-containing] A,  Serum albumin,  Sodium-dependent noradrenaline transporter,  Sodium-dependent dopamine transporter,  Sodium-dependent serotonin transporter"
DB03085,Glycolic acid,approved; investigational,OCC(O)=O,C2H4O3,1,"Acetates, Acids, Acyclic, Dermatologicals, Hydroxy Acids, Keratolytic Agents", Glucose-6-phosphate 1-dehydrogenase
DB00858,Drostanolone,illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C,C20H32O2,1,"Androstanes, Fused-Ring Compounds, Steroids"," Androgen receptor,  Cytochrome P450 19A1,  Sex hormone-binding globulin"
DB00860,Prednisolone,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C21H28O5,1,"Adrenal Cortex Hormones, Adrenals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Alimentary Tract and Metabolism, Anti-Inflammatory Agents, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Antidotes, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids Acting Locally, Corticosteroids for Local Oral Treatment, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Corticosteroids, Dermatological Preparations, Corticosteroids, Weak (Group I), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Intestinal Antiinflammatory Agents, Nasal Preparations, Ophthalmological and Otological Preparations, Ophthalmologicals, Otologicals, P-glycoprotein substrates, Prednisolone and Prodrugs, Pregnadienes, Pregnadienetriols, Pregnanes, Sensory Organs, Steroids, Stomatological Preparations, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Vasoprotectives"," Glucocorticoid receptor,  Cytochrome P450 3A4,  Corticosteroid-binding globulin,  Serum albumin,  Solute carrier organic anion transporter family member 1A2,  P-glycoprotein 1"
DB12248,Tulobuterol,investigational,CC(C)(C)NCC(O)C1=CC=CC=C1Cl,C12H18ClNO,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Drugs for Obstructive Airway Diseases, Ethanolamines, Neurotransmitter Agents, Peripheral Nervous System Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists", Beta-2 adrenergic receptor
DB00866,Alprenolol,experimental; withdrawn,CC(C)NCC(O)COC1=CC=CC=C1CC=C,C15H23NO2,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antidepressive Agents, Antihypertensive Agents, Autonomic Agents, Beta Blocking Agents, Non-Selective, Bradycardia-Causing Agents, Cardiovascular Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Neurotransmitter Agents, Peripheral Nervous System Agents, Phenoxypropanolamines, Propanolamines, Propanols, Serotonin 5-HT1 Receptor Antagonists, Serotonin 5-HT1A Receptor Antagonists, Serotonin Agents, Serotonin Receptor Antagonists, Sympatholytics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  5-hydroxytryptamine receptor 1A,  Beta-3 adrenergic receptor,  Cytochrome P450 2D6"
DB12255,Vadadustat,approved; investigational,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,C14H11ClN2O4,1,"Amino Acids, Amino Acids, Peptides, and Proteins, Antianemic Preparations, BCRP/ABCG2 Inhibitors, Blood and Blood Forming Organs, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (weak), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Erythropoiesis-Stimulating Agents, Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors, OAT3/SLC22A8 Inhibitors, OAT3/SLC22A8 Substrates, Pyridines, UGT1A1 Inducers, UGT1A1 Substrates, UGT1A9 Substrates, UGT2B7 substrates"," Egl nine homolog 1,  Egl nine homolog 2,  Egl nine homolog 3,  Hypoxia-inducible factor 1-alpha,  Endothelial PAS domain-containing protein 1,  UDP-glucuronosyltransferase 1-1,  UDP-glucuronosyltransferase 1-7,  UDP-glucuronosyltransferase 1-8,  UDP-glucuronosyltransferase 1-9,  UDP-glucuronosyltransferase 2B7,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 3A4,  Cytochrome P450 2C9,  Serum albumin,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 8,  Solute carrier family 22 member 6"
DB00871,Terbutaline,approved,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,C12H19NO3,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Cholinesterase Inhibitors, Drugs for Obstructive Airway Diseases, Drugs that are Mainly Renally Excreted, Ethanolamines, Neurotransmitter Agents, OCT2 Substrates, Peripheral Nervous System Agents, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Reproductive Control Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetics, Tocolytic Agents"," Beta-2 adrenergic receptor,  Beta-3 adrenergic receptor,  Beta-1 adrenergic receptor,  Sulfotransferase (Protein Group),  UDP-glucuronosyltransferases (UGTs) (Protein Group),  Cholinesterase,  Solute carrier family 22 member 5,  Solute carrier family 22 member 2"
DB00872,Conivaptan,approved; investigational,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1,C32H26N4O2,1,"Antidiuretic Hormone Receptor Antagonists, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Diuretics, Heterocyclic Compounds, Fused-Ring, Hypotensive Agents, Narrow Therapeutic Index Drugs, Natriuretic Agents, P-glycoprotein inhibitors"," Vasopressin V1a receptor,  Vasopressin V2 receptor,  Cytochrome P450 3A4,  P-glycoprotein 1"
DB12266,Epofolate,investigational,[H][C@]1(C)CCC[C@@H]2[C@H](C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C1=CSC(C)=N1)N2CCOC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C1=CC=C(NCC2=CN=C3N=C(N)NC(=O)C3=N2)C=C1)C(O)=O)C(O)=O,C67H92N16O22S3,1,"Anti-Bacterial Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Heterocyclic Compounds, Fused-Ring, Lactones, Macrolides, Polyketides, Pteridines, Pterins", Cytochrome P450 3A4
DB00880,Chlorothiazide,approved; vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,C7H6ClN3O4S2,1,"Antihypertensive Agents, Benzothiadiazines, Cardiovascular Agents, Diuretics, Drugs causing inadvertant photosensitivity, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, Heterocyclic Compounds, Fused-Ring, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis, Membrane Transport Modulators, Natriuretic Agents, OAT1/SLC22A6 inhibitors, Photosensitizing Agents, Sodium Chloride Symporter Inhibitors, Sulfonamides, Sulfones, Sulfur Compounds, Thiazides"," Solute carrier family 12 member 3,  Carbonic anhydrase 1,  Carbonic anhydrase 2,  Solute carrier family 22 member 6"
DB00882,Clomifene,approved; investigational,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,C26H28ClNO,1,"Benzene Derivatives, Benzylidene Compounds, Clomiphene, Estrogen Agonist-antagonists, Estrogen Agonist/Antagonist, Estrogen Antagonists, Estrogen Receptor Modulators, Fertility Agents, Fertility Agents, Female, Genito Urinary System and Sex Hormones, Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Ovulation Stimulants, Synthetic, P-glycoprotein substrates, Reproductive Control Agents, Selective Estrogen Receptor Modulators, Sex Hormones and Modulators of the Genital System, Stilbenes"," Estrogen receptor alpha,  Sex hormone-binding globulin,  Steroid 17-alpha-hydroxylase/17,20 lyase,  P-glycoprotein 1"
DB00887,Bumetanide,approved,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,C17H20N2O5S,1,"Acids, Carbocyclic, Agents Causing Muscle Toxicity, Amides, Aminobenzoates, Benzene Derivatives, Benzoates, Cardiovascular Agents, Diuretics, Drugs causing inadvertant photosensitivity, Drugs that are Mainly Renally Excreted, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, High-Ceiling Diuretics, High-Ceiling Diuretics and Potassium-Sparing Agents, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis at Loop of Henle, Membrane Transport Modulators, meta-Aminobenzoates, Natriuretic Agents, Nephrotoxic agents, Non Potassium Sparing Diuretics, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Inhibitors, OAT3/SLC22A8 Substrates, Photosensitizing Agents, Sodium Potassium Chloride Symporter Inhibitors, Sulfonamides, Sulfones, Sulfur Compounds"," Solute carrier family 12 member 1,  Solute carrier family 12 member 2,  Solute carrier family 12 member 4,  Solute carrier family 12 member 5,  Cystic fibrosis transmembrane conductance regulator,  Prostaglandin G/H synthase 2,  Sodium/bile acid cotransporter,  Solute carrier family 22 member 6,  Solute carrier family 22 member 8,  Solute carrier family 22 member 11,  Solute carrier family 22 member 7,  Solute carrier organic anion transporter family member 1A2"
DB00893,Iron Dextran,approved; vet_approved,,,1,"Compounds used in a research, industrial, or household setting, Dextrans, Hematinics, Iron Compounds, Iron Preparations, Parenteral Iron Replacement, Supplements"," Hemoglobin subunit beta,  Hemoglobin subunit alpha,  Ferritin heavy chain,  Ferritin light chain,  Serotransferrin"
DB00894,Testolactone,approved; investigational,[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H],C19H24O3,1,"Androstadienes, Androstanes, Androstenes, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Aromatase Inhibitors, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Homosteroids, Steroids", Cytochrome P450 19A1
DB00903,Etacrynic acid,approved; investigational,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,C13H12Cl2O4,1,"Acetates, Acids, Acyclic, Agents that produce neuromuscular block (indirect), Aryloxyacetic Acid Derivatives, Diuretics, Enzyme Inhibitors, Glycolates, High-Ceiling Diuretics, Hydroxy Acids, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis at Loop of Henle, Natriuretic Agents, Nephrotoxic agents, Non Potassium Sparing Diuretics, OAT1/SLC22A6 inhibitors, Ototoxic agents, Phenoxyacetates, Sodium Potassium Chloride Symporter Inhibitors"," Solute carrier family 12 member 1,  Sodium/potassium-transporting ATPase subunit alpha-1,  Lymphoid enhancer-binding factor 1,  Glutathione S-transferase P,  Glutathione S-transferase A2,  Serum albumin,  Solute carrier family 22 member 6"
DB00907,Cocaine,approved; illicit,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C,C17H21NO4,1,"Agents producing tachycardia, Agents that reduce seizure threshold, Alkaloids, Analgesics and Anesthetics, Anesthetics, Anesthetics, Local, Anticholinergic Agents, Aza Compounds, Azabicyclo Compounds, Cardiovascular Agents, Central Nervous System Agents, Central Nervous System Stimulants, Cholinesterase substrates, Cocaine, antagonists & inhibitors, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dopamine Agents, Dopamine Uptake Inhibitors, Esters of Benzoic Acid, Highest Risk QTc-Prolonging Agents, Local Anesthetics (Ester), Membrane Transport Modulators, Muscarinic Antagonists, Nervous System, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, OCT2 Inhibitors, Ophthalmologicals, QTc Prolonging Agents, Sensory Organs, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Throat Preparations, Tropanes, Vasoconstrictor Agents"," Sodium-dependent dopamine transporter,  Sodium-dependent noradrenaline transporter,  Sodium channel protein (Protein Group),  Sodium-dependent serotonin transporter,  Muscarinic acetylcholine receptor M1,  Muscarinic acetylcholine receptor M2,  Sigma non-opioid intracellular receptor 1,  Liver carboxylesterase 1,  Cytochrome P450 3A4,  Cytochrome P450 2D6,  Cytochrome P450 2C8,  Cholinesterase,  Liver carboxylesterase 1,  alpha1-acid glycoprotein (Protein Group),  Solute carrier family 22 member 2,  Sodium-dependent dopamine transporter"
DB00921,Buprenorphine,approved; illicit; investigational; vet_approved,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,C29H41NO4,1,"Alkaloids, Analgesics, BCRP/ABCG2 Inhibitors, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs Used in Addictive Disorders, Drugs Used in Opioid Dependence, Heterocyclic Compounds, Fused-Ring, Mixed Agonist / Antagonist Opioids, Morphinans, Narcotics, Nervous System, Opiate Agonists, Opiate Alkaloids, Opiate Partial Agonists, Opioid Antagonists, Opioids, Oripavine Derivatives, P-glycoprotein inhibitors, Peripheral Nervous System Agents, Phenanthrenes, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, UGT1A1 Substrates, UGT1A9 Substrates"," Kappa-type opioid receptor,  Mu-type opioid receptor,  Delta-type opioid receptor,  Nociceptin receptor,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 2C9,  Cytochrome P450 2C8,  Cytochrome P450 3A7,  Cytochrome P450 2D6,  Cytochrome P450 2C18,  Cytochrome P450 2C19,  P-glycoprotein 1,  ATP-binding cassette sub-family G member 2"
DB00938,Salmeterol,approved,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,C25H37NO4,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics, Inhalants, Agents Causing Muscle Toxicity, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Ethanolamines, Ethylamines, Long-acting beta-adrenoceptor agonists, Neurotransmitter Agents, OCT1 inhibitors, OCT1 substrates, OCT2 Inhibitors, Peripheral Nervous System Agents, Phenethylamines, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetic (Adrenergic) Agents"," Beta-2 adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-3 adrenergic receptor,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C8,  Serum albumin,  alpha1-acid glycoprotein (Protein Group),  Solute carrier family 22 member 1,  Solute carrier family 22 member 3,  Solute carrier family 22 member 2"
DB15133,Tepotinib,approved; investigational,CN1CCC(COC2=CN=C(N=C2)C2=CC(CN3N=C(C=CC3=O)C3=CC(=CC=C3)C#N)=CC=C2)CC1,C29H28N6O2,1,"Antineoplastic Agents, Antineoplastic and Immunomodulating Agents, BCRP/ABCG2 Inhibitors, BSEP/ABCB11 Inhibitors, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strong), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Kinase Inhibitor, MATE 1 Inhibitors, MATE 2 Inhibitors, MATE inhibitors, Mesenchymal Epithelial Transition Inhibitors, OCT1 inhibitors, OCT2 Inhibitors, P-glycoprotein inhibitors, P-glycoprotein substrates, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-met, antagonists & inhibitors, Tyrosine Kinase Inhibitors"," Hepatocyte growth factor receptor,  Nischarin,  Melatonin receptor type 1B,  Cytochrome P450 3A4,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Serum albumin,  Alpha-1-acid glycoprotein 1,  P-glycoprotein 1,  ATP-binding cassette sub-family G member 2,  Solute carrier family 22 member 1,  Solute carrier family 22 member 2,  Multidrug and toxin extrusion protein 1,  Multidrug and toxin extrusion protein 2,  Bile salt export pump"
DB00947,Fulvestrant,approved; investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],C32H47F5O3S,1,"Anti-Estrogens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Endocrine Therapy, Estradiol Congeners, Estranes, Estrenes, Estrogen Antagonists, Estrogen Receptor Antagonists, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Selective Estrogen Receptor Modulators, Steroids, UGT1A1 Substrates"," Estrogen receptor alpha,  Cytochrome P450 3A4,  UDP-glucuronosyltransferase 1-1"
DB00959,Methylprednisolone,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,C22H30O5,1,"Adrenal Cortex Hormones, Adrenals, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Anti-Inflammatory Agents, Antiemetics, Antineoplastic Agents, Autonomic Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Corticosteroids, Dermatological Preparations, Corticosteroids, Weak (Group I), Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Experimental Unapproved Treatments for COVID-19, Fused-Ring Compounds, Gastrointestinal Agents, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Neuroprotective Agents, Ophthalmological and Otological Preparations, Ophthalmologicals, P-glycoprotein inducers, P-glycoprotein substrates, Peripheral Nervous System Agents, Pregnadienes, Pregnadienetriols, Pregnanes, Protective Agents, Sensory Organs, Steroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"," Glucocorticoid receptor,  Annexin A1,  20-ketosteroid reductase (20-hydroxysteroid dehydrogenase) (Protein Group),  11beta-hydroxysteroid dehydrogenase (Protein Group),  Cytochrome P450 3A4,  Cytochrome P450 3A Subfamily (Protein Group),  Cytochrome P450 2A6,  Cytochrome P450 1B1,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 2C19, 10. Cytochrome P450 2C9,  Serum albumin,  P-glycoprotein 1"
DB00960,Pindolol,approved; investigational,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,C14H20N2O2,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antidepressive Agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Beta Blocking Agents, Non-Selective, Bradycardia-Causing Agents, Cardiovascular Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Hypotensive Agents, Neurotransmitter Agents, OCT2 Substrates, Phenoxypropanolamines, Propanolamines, Propanols, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 5-HT1 Receptor Antagonists, Serotonin 5-HT1A Receptor Antagonists, Serotonin Agents, Serotonin Receptor Antagonists, Vasodilating Agents"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Beta-3 adrenergic receptor,  5-hydroxytryptamine receptor 1A,  5-hydroxytryptamine receptor 1B,  UDP-glucuronosyltransferases (UGTs) (Protein Group),  Sulfotransferase (Protein Group),  Cytochrome P450 2D6,  alpha1-acid glycoprotein (Protein Group),  Solute carrier family 22 member 2"
DB12370,Ipamorelin,investigational,CC(C)(N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O,C38H49N9O5,1,"Amino Acids, Peptides, and Proteins, Peptides",
DB15198,Dextromethadone,investigational,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,C21H27NO,1,"Analgesics, Analgesics, Non-Narcotic, Central Nervous System Agents, Ketones, Peripheral Nervous System Agents, Sensory System Agents",
DB00983,Formoterol,approved; investigational,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1,C19H24N2O4,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Ethanolamines, Long-acting beta-adrenoceptor agonists, OCT1 inhibitors, OCT1 substrates, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, UGT1A9 Substrates, UGT2B7 substrates"," Beta-2 adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-3 adrenergic receptor,  Cytochrome P450 2D6,  Cytochrome P450 2C19,  Cytochrome P450 2C9,  Cytochrome P450 2A6,  UDP-glucuronosyltransferase 1-8,  UDP-glucuronosyltransferase 1-9,  UDP-glucuronosyltransferase 2B7,  UDP-glucuronosyltransferase 2B15,  Serum albumin,  Solute carrier family 22 member 1,  Solute carrier family 22 member 3,  Solute carrier family 22 member 4,  Solute carrier family 22 member 5"
DB00984,Nandrolone phenpropionate,approved; illicit; investigational,[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],C27H34O3,1,"Anabolic Agents, Androgens, Estranes, Estrenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Nandrolone and esters, Steroids, Testosterone Congeners, Thyroxine-binding globulin inhibitors", Androgen receptor
DB15205,Capromorelin,investigational,CN1N=C2CCN(C[C@@]2(CC2=CC=CC=C2)C1=O)C(=O)[C@@H](COCC1=CC=CC=C1)NC(=O)C(C)(C)N,C28H35N5O4,1,,
DB00990,Exemestane,approved; investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,C20H24O2,1,"Androstanes, Androstenes, Antineoplastic Agents, Antineoplastic and Immunomodulating Agents, Aromatase Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Endocrine Therapy, Enzyme Inhibitors, Estrogen Antagonists, Fused-Ring Compounds, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroid Synthesis Inhibitors, Steroids"," Cytochrome P450 19A1,  Cytochrome P450 19A1,  Cytochrome P450 3A4"
DB00999,Hydrochlorothiazide,approved; vet_approved,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,C7H8ClN3O4S2,1,"Amides, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Benzothiadiazines, Cardiovascular Agents, Diuretics, Drugs causing inadvertant photosensitivity, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, Heterocyclic Compounds, Fused-Ring, Hyperglycemia-Associated Agents, Hypotensive Agents, Increased Diuresis, Low-Ceiling Diuretics and Potassium-Sparing Agents, Membrane Transport Modulators, Natriuretic Agents, Nephrotoxic agents, Non Potassium Sparing Diuretics, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Photosensitizing Agents, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Sodium Chloride Symporter Inhibitors, Sulfonamides, Sulfones, Sulfur Compounds, Thiazides"," Solute carrier family 12 member 3,  Calcium-activated potassium channel subunit alpha-1,  Serum albumin,  Solute carrier family 22 member 6,  Solute carrier family 22 member 8,  Solute carrier family 22 member 11,  Multidrug resistance-associated protein 4"
DB08357,Diethylene glycol diethyl ether,experimental,CCOCCOCCOCC,C8H18O3,1,," Acetylcholinesterase,  Uncharacterized lipoprotein YbbD,  Phosphoenolpyruvate-protein phosphotransferase"
DB01001,Salbutamol,approved; vet_approved,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,C13H21NO3,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Drugs for Obstructive Airway Diseases, Drugs that are Mainly Renally Excreted, Ethanolamines, Peripheral Nervous System Agents, Phenethylamines, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Reproductive Control Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetic (Adrenergic) Agents, Tocolytic Agents"," Beta-2 adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-3 adrenergic receptor,  Cytochrome P450 3A4"
DB01006,Letrozole,approved; investigational,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,C17H11N5,1,"Agents Causing Muscle Toxicity, Antineoplastic Agents, Antineoplastic and Immunomodulating Agents, Aromatase Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors (strong), Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Endocrine Therapy, Enzyme Inhibitors, Estrogen Antagonists, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Nitriles, P-glycoprotein substrates, Steroid Synthesis Inhibitors, Triazoles, UGT2B7 substrates"," Cytochrome P450 19A1,  Cytochrome P450 2C19,  UDP-glucuronosyltransferase 2B7,  Cytochrome P450 3A4,  Cytochrome P450 2A6,  Cytochrome P450 19A1,  Serum albumin,  P-glycoprotein 1"
DB08366,"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",experimental,[H][C@]12C[C@]3([H])O[C@@]1(C)C[C@@]1(C2)CCC(=O)[C@@](C)(CCC(=O)NC2=C(O)C=CC(C(O)=O)=C2O)[C@]31[H],C24H29NO7,1,, 3-oxoacyl-[acyl-carrier-protein] synthase 2
DB05804,Prasterone sulfate,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O,C19H28O5S,1,"17-Ketosteroids, Adrenal Cortex Hormones, Androstanes, Androstenes, Androstenols, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A7 Substrates, Dehydroepiandrosterone, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Ketosteroids, Steroids, Testosterone Congeners"," Cytochrome P450 19A1,  Cytochrome P450 3A7,  Prostaglandin G/H synthase 2,  Solute carrier family 22 member 8,  Solute carrier organic anion transporter family member 1A2,  Solute carrier organic anion transporter family member 1B1,  Solute carrier organic anion transporter family member 1B3,  Solute carrier organic anion transporter family member 2B1,  Solute carrier family 10 member 6,  Bile salt export pump"
DB05805,NS-2359,investigational,COC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C,C16H21Cl2NO,1,"Alkaloids, Aza Compounds, Azabicyclo Compounds, Neurotransmitter Uptake Inhibitors",
DB05830,Trestolone,investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],C19H28O2,1,"Adrenal Cortex Hormones, Contraceptive Agents, Hormonal, Contraceptive Agents, Male, Estranes, Estrenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormonal Contraceptives for Systemic Use, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Reproductive Control Agents, Steroids, Testosterone Congeners",
DB08387,Mardepodect,investigational,CN1C=C(C(=N1)C1=CC=C(OCC2=NC3=CC=CC=C3C=C2)C=C1)C1=CC=NC=C1,C25H20N4O,1,"Heterocyclic Compounds, Fused-Ring"," cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A"
DB08388,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",experimental,CCOCCC1(OC2=CC=C(OC3=CC=C(F)C=C3)C=C2)C(=O)NC(=O)NC1=O,C20H19FN2O6,1,, Collagenase 3
DB01032,Probenecid,approved; investigational,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,C13H19NO4S,1,"Adjuvants, Pharmaceutic, Amides, Antigout Preparations, Antirheumatic Agents, Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Drugs that are Mainly Renally Excreted, Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics, Musculo-Skeletal System, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Inhibitors, OCT1 inhibitors, OCT2 Inhibitors, Pharmaceutic Aids, Pharmaceutical Preparations, Preparations Increasing Uric Acid Excretion, Sulfonamides, Sulfones, Sulfur Compounds, UGT1A1 Inhibitors, Uricosuric Agents"," Solute carrier family 22 member 6,  Solute carrier family 22 member 11,  Solute carrier family 22 member 8,  Pannexin-1,  Taste receptor type 2 member 16,  Cytochrome P450 2C8,  Cytochrome P450 3A4,  UDP-glucuronosyltransferase 1-1,  Cytochrome P450 2C9,  Serum albumin,  Solute carrier family 22 member 2,  Solute carrier family 22 member 1,  Canalicular multispecific organic anion transporter 2,  Multidrug resistance-associated protein 4,  Multidrug resistance-associated protein 5,  Monocarboxylate transporter 2,  Solute carrier family 22 member 5,  Multidrug resistance-associated protein 6,  Multidrug resistance-associated protein 1, 10. Solute carrier organic anion transporter family member 1A2, 11. Monocarboxylate transporter 1, 12. Sodium/bile acid cotransporter, 13. Solute carrier family 22 member 6, 14. Solute carrier family 22 member 10, 15. Solute carrier family 22 member 8, 16. Canalicular multispecific organic anion transporter 1, 17. ATP-binding cassette sub-family C member 11, 18. Solute carrier family 22 member 11, 19. Solute carrier organic anion transporter family member 1C1, 20. Solute carrier family 22 member 7, 21. Solute carrier family 22 member 12, 22. Solute carrier family 2, facilitated glucose transporter member 9"
DB01037,Selegiline,approved; investigational; vet_approved,C[C@H](CC1=CC=CC=C1)N(C)CC#C,C13H17N,1,"Agents that produce hypertension, Agents that reduce seizure threshold, Amines, Anti-Dyskinesia Agents, Anti-Parkinson Drugs, Antidepressive Agents, Antidepressive Agents Indicated for Depression, Central Nervous System Agents, Central Nervous System Depressants, Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dopamine Agents, Enzyme Inhibitors, Ethylamines, Hypotensive Agents, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Monoamine Oxidase B Inhibitors, Monoamine Oxidase Inhibitors, Nervous System, Neuroprotective Agents, P-glycoprotein inhibitors, Phenethylamines, Protective Agents, Psychotropic Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents, Serotonin Modulators"," Amine oxidase [flavin-containing] B,  Amine oxidase [flavin-containing] A,  Cytochrome P450 2B6,  Cytochrome P450 3A4,  Cytochrome P450 2A6,  Cytochrome P450 1A2,  Cytochrome P450 2C19,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Cytochrome P450 2D6,  P-glycoprotein 1"
DB08426,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",experimental,[H][C@@]1(CCN(CC2=CC3=C(N2)C=NC=C3)C1=O)NS(=O)(=O)C1=CC2=C(S1)C=CC=N2,C19H17N5O3S2,1,, Coagulation factor X
DB15339,Methcathinone,investigational,CNC(C)C(=O)C1=CC=CC=C1,C10H13NO,1,Ketones,
DB03322,Dexpropranolol,experimental,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CC=C2,C16H21NO2,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Cardiovascular Agents, Naphthalenes, Neurotransmitter Agents, Phenoxypropanolamines, Propanolamines, Propanols, Vasodilating Agents",
DB15374,Cobalt Co-60,investigational,[60Co],Co,1,"Cobalt Isotopes, Elements, Isotopes, Metals, Metals, Heavy, Radioisotopes, Transition Elements",
DB01105,Sibutramine,approved; illicit; investigational; withdrawn,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,C17H26ClN,1,"Agents producing tachycardia, Alimentary Tract and Metabolism, Anti-Obesity Agents, Antidepressive Agents, Antiobesity Preparations, Excl. Diet Products, Appetite Depressants, Appetite Suppression, Central Nervous System Agents, Central Nervous System Depressants, Centrally Acting Antiobesity Products, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Cycloparaffins, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Dopamine Uptake Inhibitors, Drugs that are Mainly Renally Excreted, Norepinephrine Uptake Inhibitors, Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic, Psychotropic Drugs, Selective Serotonin Reuptake Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents, Serotonin and Noradrenaline Reuptake Inhibitors, Serotonin Modulators, Stimulants"," Sodium-dependent dopamine transporter,  Sodium-dependent serotonin transporter,  Sodium-dependent noradrenaline transporter,  Cytochrome P450 3A4"
DB03350,Cobalt hexammine ion,experimental,[NH3+][Co-3]([NH3+])([NH3+])([NH3+])([NH3+])[NH3+],CoH18N6,1,," Outer membrane protein TolC,  Chorismate synthase"
DB03368,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",experimental,CC1(C(=O)NC(=O)NC1=O)C1=CC=C(OC2=CC=CC=C2)C=C1,C17H14N2O4,1,, Stromelysin-1
DB01136,Carvedilol,approved; investigational,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,C24H26N2O4,1,"Adrenergic Agents, Adrenergic alpha-1 Receptor Antagonists, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Adrenergic beta2-Antagonists, Agents causing hyperkalemia, Alcohols, Alpha and Beta Blocking Agents, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Antioxidants, Biological Factors, Bradycardia-Causing Agents, Calcium Channel Blockers, Calcium-Regulating Hormones and Agents, Carbazoles, Cardiovascular Agents, Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Heterocyclic Compounds, Fused-Ring, Hypotensive Agents, Indoles, Membrane Transport Modulators, Negative Inotrope, Neurotransmitter Agents, P-glycoprotein inhibitors, Propanolamines, Propanols, Protective Agents, UGT1A1 Substrates, UGT2B7 substrates, Vasodilating Agents"," Beta-1 adrenergic receptor,  Alpha-1A adrenergic receptor,  Alpha-1 adrenergic receptors (Protein Group),  NADH dehydrogenase [ubiquinone] 1 subunit C2,  Beta-2 adrenergic receptor,  Vascular endothelial growth factor A,  Natriuretic peptides B,  Gap junction alpha-1 protein,  Potassium voltage-gated channel subfamily H member 2, 10. Vascular cell adhesion protein 1, 11. Alpha-1D adrenergic receptor, 12. Alpha-1B adrenergic receptor, 13. Alpha-2C adrenergic receptor, 14. Alpha-2B adrenergic receptor, 15. Alpha-2A adrenergic receptor, 16. E-selectin, 17. Hypoxia-inducible factor 1-alpha, 18. Inward rectifier potassium channel 4, 19. Inward rectifier potassium channel 2,  Cytochrome P450 1A2,  Cytochrome P450 3A4,  Cytochrome P450 1A1,  Cytochrome P450 2E1,  UDP-glucuronosyltransferase 1-1,  UDP-glucuronosyltransferase 2B4,  UDP-glucuronosyltransferase 2B7,  Cytochrome P450 2C9,  Cytochrome P450 2D6, 10. Xanthine dehydrogenase/oxidase,  Serum albumin,  P-glycoprotein 1"
DB15429,Thioglycolic acid,investigational,OC(=O)CS,C2H4O2S,1,"Acetates, Acids, Acyclic, Sulfhydryl Compounds, Sulfur Compounds",
DB03394,Heptaethylene glycol,experimental,OCCOCCOCCOCCOCCOCCOCCO,C14H30O8,1,Pegylated agents, Carbonyl reductase [NADPH] 1
DB01185,Fluoxymesterone,approved; illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C20H29FO3,1,"3-Oxoandrosten (4) Derivatives, Anabolic Agents, Androgens, Androstanes, Androstenediols, Androstenes, Androstenols, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Sex Hormones and Modulators of the Genital System, Steroids, Steroids, Fluorinated"," Androgen receptor,  Estrogen receptor alpha,  Glucocorticoid receptor,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  Sex hormone-binding globulin"
DB01191,Dexfenfluramine,approved; illicit; investigational; withdrawn,CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F,C12H16F3N,1,"Alimentary Tract and Metabolism, Amines, Antidepressive Agents, Antiobesity Preparations, Excl. Diet Products, Central Nervous System Depressants, Centrally Acting Antiobesity Products, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inhibitors (weak), Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Ethylamines, Neurotransmitter Agents, Phenethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents"," Sodium-dependent serotonin transporter,  5-hydroxytryptamine receptor 2C,  Cytochrome P450 1A2,  Cytochrome P450 2E1,  Cytochrome P450 2D6"
DB01192,Oxymorphone,approved; investigational; vet_approved,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,C17H19NO4,1,"Adjuvants, Adjuvants, Anesthesia, Alkaloids, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Heterocyclic Compounds, Fused-Ring, High-risk opioids, Morphinans, Morphine Derivatives, Narcotics, Natural Opium Alkaloids, Nervous System, Opiate Agonists, Opiate Alkaloids, Opioid Agonist, Opioids, Peripheral Nervous System Agents, Phenanthrenes, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"," Mu-type opioid receptor,  Delta-type opioid receptor,  Cytochrome P450 3A4,  Cytochrome P450 2D6"
DB01193,Acebutolol,approved; investigational,CCCC(=O)NC1=CC=C(OCC(O)CNC(C)C)C(=C1)C(C)=O,C18H28N2O4,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Autonomic Agents, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Selective, Beta Blocking Agents, Selective, and Thiazides, Beta-Blockers (Beta1 Selective), Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Hypotensive Agents, Neurotransmitter Agents, P-glycoprotein substrates, Peripheral Nervous System Agents, Phenoxypropanolamines, Propanolamines, Propanols, QTc Prolonging Agents, Sympathomimetics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Cytochrome P450 2D6,  P-glycoprotein 1"
DB12643,Nelivaptan,investigational,[H][C@]1(O)CN([C@@]([H])(C1)C(=O)N(C)C)[C@@]1(C(=O)N(C2=C1C=C(Cl)C=C2)S(=O)(=O)C1=C(OC)C=C(OC)C=C1)C1=CC=CC=C1OC,C30H32ClN3O8S,1,"Heterocyclic Compounds, Fused-Ring",
DB15566,Prednisolone acetate,approved; vet_approved,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C23H30O6,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, P-glycoprotein substrates, Pregnadienes, Pregnadienetriols, Pregnanes, Prodrugs, Steroids"," Glucocorticoid receptor,  Cytochrome P450 3A4,  Corticosteroid-binding globulin,  Serum albumin,  Solute carrier organic anion transporter family member 1A2,  P-glycoprotein 1"
DB01203,Nadolol,approved,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,C17H27NO4,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antihypertensive Agents, Antihypertensive Agents Indicated for Hypertension, Autonomic Agents, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Beta Blocking Agents, Non-Selective, and Thiazides, Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Drugs causing inadvertant photosensitivity, Drugs that are Mainly Renally Excreted, Hypotensive Agents, MATE 1 Substrates, MATE 2 Substrates, MATE substrates, Negative Inotrope, Neurotransmitter Agents, P-glycoprotein substrates, Peripheral Nervous System Agents, Phenoxypropanolamines, Photosensitizing Agents, Propanolamines, Propanols, Sympatholytics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  alpha1-acid glycoprotein (Protein Group),  P-glycoprotein 1,  POU domain, class 2, transcription factor 1,  POU domain, class 2, transcription factor 2,  Multidrug and toxin extrusion protein 1,  Multidrug and toxin extrusion protein 2"
DB06212,Tolvaptan,approved,CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2,C26H25ClN2O3,1,"Agents causing hyperkalemia, Antidiuretic Hormone Receptor Antagonists, Benzazepines, Cardiovascular Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Diuretics, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Natriuretic Agents, P-glycoprotein inhibitors, P-glycoprotein substrates, P-glycoprotein substrates with a Narrow Therapeutic Index, Vasopressin V2 Receptor Antagonist, Vasopressin V2 Receptor Antagonists"," Vasopressin V2 receptor,  Vasopressin V1a receptor,  Cytochrome P450 3A4,  P-glycoprotein 1"
DB01210,Levobunolol,approved,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,C17H25NO3,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiglaucoma Preparations and Miotics, Autonomic Agents, Beta-adrenergic Agents, Bradycardia-Causing Agents, Bunolol, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Hypotensive Agents, Naphthalenes, Neurotransmitter Agents, Ophthalmologicals, Peripheral Nervous System Agents, Phenoxypropanolamines, Propanolamines, Propanols, Sensory Organs, Sympatholytics, Tetrahydronaphthalenes"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Cytochrome P450 2D6"
DB01214,Metipranolol,approved,CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1,C17H27NO4,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Antiarrhythmic agents, Antiglaucoma Preparations and Miotics, Antihypertensive Agents, Autonomic Agents, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, and Thiazides, Bradycardia-Causing Agents, Cardiovascular Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Hypotensive Agents, Neurotransmitter Agents, Ophthalmologicals, Peripheral Nervous System Agents, Phenoxypropanolamines, Propanolamines, Propanols, Sensory Organs, Sympatholytics"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Cytochrome P450 2D6"
DB01217,Anastrozole,approved; investigational,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,C17H19N5,1,"Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, Aromatase Inhibitors, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Endocrine Therapy, Enzyme Inhibitors, Estrogen Antagonists, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Nitriles, P-glycoprotein substrates, Steroid Synthesis Inhibitors, Triazoles, UGT1A3 substrates, UGT1A4 substrates, UGT2B7 substrates"," Cytochrome P450 19A1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 2C8,  UDP-glucuronosyltransferase 1-4,  UDP-glucuronosyltransferase 1-3,  UDP-glucuronosyltransferase 2B7,  Cytochrome P450 1A2,  Cytochrome P450 2C9,  P-glycoprotein 1"
DB01222,Budesonide,approved,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C25H34O6,1,"Adrenal Cortex Hormones, Adrenals, Agents to Treat Airway Disease, Alimentary Tract and Metabolism, Anti-Asthmatic Agents, Anti-Inflammatory Agents, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Autonomic Agents, Bronchodilator Agents, BSEP/ABCB11 Substrates, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids Acting Locally, Corticosteroids for Systemic Use, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (moderate), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Drugs for Obstructive Airway Diseases, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Immunosuppressive Agents, Intestinal Antiinflammatory Agents, Nasal Preparations, OAT3/SLC22A8 Substrates, P-glycoprotein substrates, Peripheral Nervous System Agents, Pregnanes, Pregnenediones, Pregnenes, Respiratory System Agents, Steroids"," Glucocorticoid receptor,  Annexin A1,  Cytochrome P450 3A5,  Cytochrome P450 3A Subfamily (Protein Group),  Cytochrome P450 2A6,  Cytochrome P450 1B1,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Cytochrome P450 2C19,  Cytochrome P450 3A4,  Corticosteroid-binding globulin,  Serum albumin,  Bile salt export pump,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1A2,  Solute carrier family 22 member 8"
DB01230,Pemoline,approved; illicit; investigational; withdrawn,NC1=NC(=O)C(O1)C1=CC=CC=C1,C9H8N2O2,1,"Central Nervous System Agents, Central Nervous System Stimulants, Centrally Acting Sympathomimetics, Nervous System, Oxazoles, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics",
DB01234,Dexamethasone,approved; investigational; vet_approved,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C22H29FO5,1,"Adrenal Cortex Hormones, Adrenals, Agents Causing Muscle Toxicity, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Alimentary Tract and Metabolism, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Anti-Inflammatory Agents, Antiemetics, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Autonomic Agents, BCRP/ABCG2 Inhibitors, BSEP/ABCB11 inducers, Central Nervous System Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Corticosteroids for Local Oral Treatment, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Corticosteroids, Dermatological Preparations, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (moderate), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Inducers, Cytochrome P-450 CYP3A7 Inducers (strength unknown), Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Dermatologicals, Experimental Unapproved Treatments for COVID-19, Fused-Ring Compounds, Gastrointestinal Agents, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Inducers of Drug Clearance, Nasal Preparations, OAT3/SLC22A8 Substrates, Ophthalmological and Otological Preparations, Ophthalmologicals, Otologicals, P-glycoprotein inducers, P-glycoprotein inhibitors, P-glycoprotein substrates, Peripheral Nervous System Agents, Pregnadienes, Pregnadienetriols, Pregnanes, Sensory Organs, Steroids, Steroids, Fluorinated, Stomatological Preparations, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Vasoprotectives"," Glucocorticoid receptor,  Nuclear receptor subfamily 0 group B member 1,  Annexin A1,  Nitric oxide synthase, inducible,  Nuclear receptor subfamily 1 group I member 2,  Corticosteroid 11-beta-dehydrogenase isozyme 2,  Cytochrome P450 3A4,  Corticosteroid 11-beta-dehydrogenase isozyme 1,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Steroid 17-alpha-hydroxylase/17,20 lyase,  Cytochrome P450 1A1,  Cytochrome P450 2A6,  Cytochrome P450 2B6, 10. Cytochrome P450 2C19, 11. Cytochrome P450 2C8, 12. Cytochrome P450 2E1, 13. Cytochrome P450 3A43, 14. Cytochrome P450 4A11, 15. Cytochrome P450 11B1, mitochondrial,  Serum albumin,  P-glycoprotein 1,  Solute carrier family 22 member 8,  Bile salt export pump,  Canalicular multispecific organic anion transporter 1,  ATP-binding cassette sub-family G member 2,  Solute carrier organic anion transporter family member 1A2"
DB01240,Epoprostenol,approved,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,C20H32O5,1,"Anticoagulants, Antihypertensive Agents, Antiplatelet agents, Autacoids, Biological Factors, Blood and Blood Forming Organs, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Eicosanoids, Fatty Acids, Fatty Acids, Unsaturated, Hematologic Agents, Hypotensive Agents, Inflammation Mediators, Lipids, Platelet Aggregation Inhibitors Excl. Heparin, Prostacyclin Analogues, Prostacycline Vasodilator, Prostaglandins, Prostaglandins I, Vasodilating Agents, Vasodilation"," Prostacyclin synthase,  P2Y purinoceptor 12,  Prostacyclin receptor"
DB15642,Molidustat,investigational,O=C1N(NC=C1N1C=CN=N1)C1=NC=NC(=C1)N1CCOCC1,C13H14N8O2,1,,
DB08619,Testosterone succinate,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCC(O)=O,C23H32O5,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone and derivatives, Testosterone Congeners, Thyroxine-binding globulin inhibitors", Neocarzinostatin
DB01255,Lisdexamfetamine,approved; investigational,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,C15H25N3O,1,"Agents producing tachycardia, Agents that produce hypertension, Amines, Amphetamines, Central Nervous System Agents, Central Nervous System Stimulants, Central Nervous System Stimulation, Centrally Acting Sympathomimetics, Dopamine Agents, Dopamine Uptake Inhibitors, Ethylamines, Membrane Transport Modulators, Nervous System, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Phenethylamines, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics"," Trace amine-associated receptor 1,  Solute carrier family 15 member 1"
DB03508,Diethylene glycol ethyl methyl ether,experimental,CCOCCOCCOC,C7H16O3,1,,
DB01274,Arformoterol,approved; investigational,COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1,C19H24N2O4,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Autonomic Agents, Bronchodilator Agents, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Ethanolamines, Long-acting beta-adrenoceptor agonists, Peripheral Nervous System Agents, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Respiratory System Agents"," Beta-2 adrenergic receptor,  Cytochrome P450 2D6,  Cytochrome P450 2C19,  Cytochrome P450 2C9,  Cytochrome P450 2A6"
DB08641,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",experimental,[H][C@@](CC)(C=O)[C@@]([H])(CNS(=O)(=O)C1=CC=C(C=C1)[N+]([O-])=O)C(O)=O,C13H16N2O7S,1,, Chymotrypsin-like elastase family member 1
DB01284,Tetracosactide,approved,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,C136H210N40O31S,1,"Adrenals, Adrenocortical Insufficiency, Adrenocorticotropic Hormone, Amino Acids, Peptides, and Proteins, Anterior Pituitary Lobe Hormones and Analogues, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Melanocortins, Nerve Tissue Proteins, Neuropeptides, Peptide Hormones, Peptides, Pituitary, Pituitary and Hypothalamic Hormones and Analogues, Pituitary Hormones, Pituitary Hormones, Anterior, Pro-Opiomelanocortin, Proteins, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins", Adrenocorticotropic hormone receptor
DB01288,Fenoterol,approved; investigational,CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1,C17H21NO4,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Anticholinergic Agents, Autonomic Agents, Benzene Derivatives, Bronchodilator Agents, Catechols, Drugs for Obstructive Airway Diseases, Ethanolamines, Genito Urinary System and Sex Hormones, Metaproterenol, Neurotransmitter Agents, Peripheral Nervous System Agents, Phenols, Reproductive Control Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetics, Sympathomimetics, Labour Repressants, Tocolytic Agents"," Beta-2 adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-3 adrenergic receptor"
DB15760,Cobaltous sulfate,experimental,[Co++].[O-]S([O-])(=O)=O,CoO4S,1,"Elements, Metals, Metals, Heavy, Transition Elements",
DB15777,Fluocortolone pivalate,experimental,[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C27H37FO5,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienediols, Pregnadienes, Pregnanes, Steroids, Steroids, Fluorinated",
DB06401,Bazedoxifene,approved; investigational,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,C30H34N2O3,1,"Bone Density Conservation Agents, Estrogen Agonist/Antagonist, Estrogen Receptor Modulators, Genito Urinary System and Sex Hormones, Heterocyclic Compounds, Fused-Ring, Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Selective Estrogen Receptor Modulators, Sex Hormones and Modulators of the Genital System, UGT1A1 Substrates, UGT1A4 substrates"," Estrogen receptor alpha,  Estrogen receptor beta,  UDP-glucuronosyltransferase 1-4,  UDP-glucuronosyltransferase 1-8,  UDP-glucuronosyltransferase 1-10"
DB03556,"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",experimental,CCOCCOCCOCCOCCOCCOCCOCCOCCO,C18H38O9,1,," Carbonyl reductase [NADPH] 1,  DevB protein"
DB06409,Morphine glucuronide,investigational,[H][C@]12C=C[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O,C23H27NO9,1,"Alkaloids, Heterocyclic Compounds, Fused-Ring, Morphinans, Opiate Alkaloids, Phenanthrenes"," Mu-type opioid receptor,  Delta-type opioid receptor,  Kappa-type opioid receptor"
DB06412,Oxymetholone,approved; illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O,C21H32O3,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Androgens, Androstan Derivatives, Androstanes, Androstanols, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Thyroxine-binding globulin inhibitors"," Androgen receptor,  Natriuretic peptides B,  Amine oxidase [flavin-containing] A,  Cytochrome P450 2D6,  3-oxo-5-alpha-steroid 4-dehydrogenase 1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 3A43,  Serum albumin,  Sex hormone-binding globulin"
DB06413,Armodafinil,approved; investigational,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,C15H15NO2S,1,"Benzene Derivatives, Benzhydryl Compounds, Central Nervous System Agents, Central Nervous System Stimulants, Centrally Acting Sympathomimetics, Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Wakefulness-Promoting Agents"," Sodium-dependent dopamine transporter,  Cytochrome P450 2C19,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 1A2,  Cytochrome P450 2B6,  Cytochrome P450 2C9"
DB12779,Higenamine,investigational,OC1=CC=C(CC2NCCC3=C2C=C(O)C(O)=C3)C=C1,C16H17NO3,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Analgesics, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Antirheumatic Agents, Cardiotonic Agents, Cardiovascular Agents, Compounds used in a research, industrial, or household setting, Fibrin Modulating Agents, Hematologic Agents, Heterocyclic Compounds, Fused-Ring, Isoquinolines, Neurotransmitter Agents, Peripheral Nervous System Agents, Protective Agents, Sensory System Agents",
DB03566,Spermidine,experimental,NCCCCNCCCN,C7H19N3,1,"Amines, Biogenic Amines, Biogenic Polyamines, OCT1 substrates, Polyamines"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Thioredoxin reductase 1, cytoplasmic,  Gentamicin 3'-acetyltransferase,  Spermidine/putrescine-binding periplasmic protein,  Solute carrier family 22 member 4,  Solute carrier family 22 member 1"
DB15821,Fluocortolone caproate,experimental,[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)CCCCC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C28H39FO5,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienediols, Pregnadienes, Pregnanes, Steroids, Steroids, Fluorinated",
DB08683,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",experimental,[H][C@]12CC[C@]([H])(O1)N1C3=C(C=CC=C3)C3=C4C(=O)NC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13,C24H15N3O3,1,, Serine/threonine-protein kinase Chk1
DB12787,Norethandrolone,investigational,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,C20H30O2,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Androstan Derivatives, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Norpregnanes, Norpregnenes, Norsteroids, Steroids",
DB01364,Ephedrine,approved,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,C10H15NO,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-Agonists, Adrenergic and Dopaminergic Agents, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Alimentary Tract and Metabolism, Alpha-and Beta-adrenergic Agonists, Amines, Amino Alcohols, Antiobesity Preparations, Excl. Diet Products, Autonomic Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy, Cardiovascular Agents, Central Nervous System Agents, Central Nervous System Stimulants, Centrally Acting Antiobesity Products, Cholinesterase substrates, Drugs for Obstructive Airway Diseases, Epinephrine and similars, Ethylamines, Herbs and Natural Products, Increased Norepinephrine Activity, Mydriatics and Cycloplegics, Nasal Preparations, Neurotransmitter Agents, Norepinephrine Releasing Agents, Ophthalmologicals, Peripheral Nervous System Agents, Phenethylamines, Propanolamines, Propanols, Sensory Organs, Sympathomimetic (Adrenergic) Agents, Sympathomimetics, Sympathomimetics Excl. Antiglaucoma Preparations, Sympathomimetics, Plain, Vasoconstrictor Agents"," Alpha-1A adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Sodium-dependent noradrenaline transporter,  Cholinesterase,  Acetylcholinesterase,  Serum albumin,  Synaptic vesicular amine transporter"
DB01365,Mephentermine,approved,CNC(C)(C)CC1=CC=CC=C1,C11H17N,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic and Dopaminergic Agents, Agents producing tachycardia, Agents that produce hypertension, Amines, Amphetamines, Autonomic Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy, Cardiovascular Agents, Ethylamines, Neurotransmitter Agents, Peripheral Nervous System Agents, Phenethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Vasoconstrictor Agents"," Alpha adrenergic receptor (Protein Group),  Beta adrenergic receptor (Protein Group)"
DB01366,Procaterol,approved; investigational,CC[C@@H](NC(C)C)[C@@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2,C16H22N2O3,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Drugs for Obstructive Airway Diseases, Ethanolamines, Heterocyclic Compounds, Fused-Ring, Hydroxyquinolines, Neurotransmitter Agents, Peripheral Nervous System Agents, Quinolines, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetics", Beta-2 adrenergic receptor
DB08704,"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",experimental,[H][C@]1(CO)O\C(=N/OC(=O)NC2=CC=CC=C2)[C@]([H])(NC(=O)CCCC)[C@@]([H])(O)[C@]1([H])O,C18H25N3O7,1,, Beta-hexosaminidase
DB01380,Cortisone acetate,approved; investigational,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C23H30O6,1,"17-Hydroxycorticosteroids, Adrenal Cortex Hormones, Adrenals, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids for Systemic Use, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydroxycorticosteroids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, OAT3/SLC22A8 Substrates, P-glycoprotein inducers, P-glycoprotein substrates, Pregnanes, Pregnenes, Steroids"," Glucocorticoid receptor,  Annexin A1,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Corticosteroid-binding globulin,  Serum albumin,  Solute carrier organic anion transporter family member 1A2,  P-glycoprotein 1,  Solute carrier family 22 member 8"
DB01406,Danazol,approved,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,C22H27NO2,1,"Androgens, Antigonadotropins and Similar Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 Enzyme Inhibitors, Estrogen Antagonists, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Pregnadienes, Pregnanes, Sex Hormones and Modulators of the Genital System, Steroids, Thyroxine-binding globulin inhibitors"," Estrogen receptor alpha,  Androgen receptor,  Progesterone receptor,  Gonadotropin-releasing hormone receptor,  Putative gonadotropin-releasing hormone II receptor,  C-C motif chemokine 2,  Cytochrome P450 3A4,  Cytochrome P450 19A1,  Sex hormone-binding globulin"
DB01407,Clenbuterol,approved; investigational; vet_approved,CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1,C12H18Cl2N2O,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Drugs for Obstructive Airway Diseases, Ethanolamines, Long-acting beta-adrenoceptor agonists, Neurotransmitter Agents, Peripheral Nervous System Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetics"," Beta-2 adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-3 adrenergic receptor,  Beta-nerve growth factor,  Tumor necrosis factor,  Cytochrome P450 1A1"
DB01410,Ciclesonide,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,C32H44O7,1,"Adrenal Cortex Hormones, Adrenals, Agents to Treat Airway Disease, Anti-Allergic Agents, Corticosteroids, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Nasal Preparations, Pregnanes, Pregnenes, Steroids, Thyroxine-binding globulin inhibitors"," Glucocorticoid receptor,  Liver carboxylesterase 1,  Cytochrome P450 3A4,  Cytochrome P450 2D6,  Corticosteroid-binding globulin"
DB12846,Reproterol,investigational,CN1C2=C(N(CCCNCC(O)C3=CC(O)=CC(O)=C3)C=N2)C(=O)N(C)C1=O,C18H23N5O5,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Alkaloids, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Benzene Derivatives, Bronchodilator Agents, Catecholamines, Catechols, Drugs for Obstructive Airway Diseases, Ethanolamines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Peripheral Nervous System Agents, Pharmaceutical Preparations, Phenols, Purines, Purinones, Respiratory System Agents, Selective Beta 2-adrenergic Agonists",
DB03622,"5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",experimental,OCCC1CCN(CC1)[C@@]1(C(=O)NC(O)=NC1=O)C1=CC=CC=C1,C17H21N3O4,1,, Neutrophil collagenase
DB01420,Testosterone propionate,approved; investigational; vet_approved; withdrawn,[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C22H32O3,1,"Androgens, Androstanes, Androstenes, Androstenols, COMT Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Steroids, Testosterone and derivatives, Testosterone Congeners, Thyroxine-binding globulin inhibitors, UGT1A1 Inducers"," Androgen receptor,  Catechol O-methyltransferase,  UDP-glucuronosyltransferase 1-1,  3-oxo-5-alpha-steroid 4-dehydrogenase (Protein Group),  Cytochrome P450 3A4,  Sex hormone-binding globulin,  Serum albumin,  P-glycoprotein 1"
DB12861,Rimeporide,investigational,CC1=CC(=C(C=C1C(=O)NC(N)=N)S(C)(=O)=O)S(C)(=O)=O,C11H15N3O5S2,1,,
DB01434,19-norandrostenedione,experimental; illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],C18H24O2,1,"17-Ketosteroids, Adrenal Cortex Hormones, Androstanes, Androstenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Ketosteroids, Steroids, Testosterone Congeners",
DB15954,Strychnine,experimental,[H][C@]12C[C@@]3([H])C4=CCO[C@@]5([H])CC(=O)N6C7=CC=CC=C7[C@@]1(CCN2C4)[C@]6([H])[C@@]35[H],C21H22N2O2,1,"Alkaloids, Central Nervous System Agents, Central Nervous System Stimulants, Compounds used in a research, industrial, or household setting, Convulsants, Glycine Agents, Heterocyclic Compounds, Fused-Ring, Indole Alkaloids, Indoles, Indolizidines, Indolizines, Neurotransmitter Agents, Noxae, Poisons, Secologanin Tryptamine Alkaloids, Toxic Actions",
DB01439,3-Methylthiofentanyl,experimental; illicit,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1,C21H28N2OS,1,," Kappa-type opioid receptor,  Mu-type opioid receptor,  Delta-type opioid receptor"
DB01443,19-Nor-5-androstenedione,experimental; illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)CC3=CC[C@@]21[H],C18H24O2,1,,
DB01448,19-Nor-4-androstenedione,experimental; illicit,,,1,,
DB01451,1-Androstenedione,experimental; illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C,C19H26O2,1,,
DB01452,Diamorphine,approved; illicit; investigational,[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5,C21H23NO5,1,"Alkaloids, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Drugs Used in Addictive Disorders, Drugs Used in Opioid Dependence, Heroin, agonists, Heterocyclic Compounds, Fused-Ring, Morphinans, Morphine Derivatives, Narcotics, Nervous System, Opiate Agonists, Opiate Alkaloids, Opioids, Peripheral Nervous System Agents, Phenanthrenes, Sensory System Agents, Thyroxine-binding globulin inducers"," Mu-type opioid receptor,  Kappa-type opioid receptor,  Delta-type opioid receptor,  Liver carboxylesterase 1,  Thyroxine-binding globulin"
DB01453,Beta-hydroxyfentanyl,experimental; illicit,CCC(=O)N(C1CCN(CC(O)C2=CC=CC=C2)CC1)C1=CC=CC=C1,C22H28N2O2,1,Piperidines,
DB15970,Chloroprednisone,experimental,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])C[C@H](Cl)C2=CC(=O)C=C[C@]12C,C21H25ClO5,1,"Ophthalmologicals, Sensory Organs",
DB01455,19-Nor-5-androstenediol,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](O)CC3=CC[C@@]21[H],C18H28O2,1,,
DB01456,5-androstenedione,experimental; illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2CC(=O)CC[C@]12C,C19H26O2,1,"17-Ketosteroids, Adrenal Cortex Hormones, Androstanes, Androstenes, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Ketosteroids, Steroids, Testosterone Congeners", Cytochrome P450 3A4
DB01458,"2,5-Dimethoxy-4-(n)-propylthiophenethylamine",experimental; illicit,CCCSC1=CC(OC)=C(CCN)C=C1OC,C13H21NO2S,1,,
DB01463,Fencamfamin,experimental; illicit; withdrawn,CCNC1C2CCC(C2)C1C1=CC=CC=C1,C15H21N,1,"Bridged-Ring Compounds, Central Nervous System Agents, Central Nervous System Depressants, Central Nervous System Stimulants, Centrally Acting Sympathomimetics, Nervous System, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Psychotropic Drugs, Tranquilizing Agents", Sodium-dependent dopamine transporter
DB15984,Clostebol acetate,experimental,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(Cl)C(=O)CC[C@]12C,C21H29ClO3,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB01466,Ethylmorphine,experimental; illicit,[H][C@@]12OC3=C(OCC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,C19H23NO3,1,"Alkaloids, Analgesics, Antitussive Agents, Central Nervous System Agents, Central Nervous System Depressants, Cough and Cold Preparations, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Heterocyclic Compounds, Fused-Ring, Morphinans, Morphine Derivatives, Narcotics, Ophthalmologicals, Opiate Alkaloids, Opioids, Opium Alkaloids and Derivatives, Peripheral Nervous System Agents, Phenanthrenes, Respiratory System Agents, Sensory Organs, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"," Mu-type opioid receptor,  Cytochrome P450 2B6,  Cytochrome P450 3A4,  Cytochrome P450 2D6,  NADPH--cytochrome P450 reductase"
DB15988,Ephedrine levulinate,experimental,CN[C@@H](C)[C@H](OC(=O)CCC(C)=O)C1=CC=CC=C1,C15H21NO3,1,,
DB01470,alpha-methylthiofentanyl,illicit,CCC(=O)N(C1CCN(CC1)C(C)CC1=CC=CS1)C1=CC=CC=C1,C21H28N2OS,1,,
DB01471,Bolasterone,experimental; illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](C)CC2=CC(=O)CC[C@]12C,C21H32O2,1,"Anabolic Agents, Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB12915,Corticorelin acetate,investigational,,,1,,
DB06622,7-beta-Hydroxyepiandrosterone,investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@@]2([H])C[C@@H](O)CC[C@]12C,C19H30O3,1,,
DB15999,Prednisolone caproate,experimental,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCCCC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C27H38O6,1,,
DB16001,Testosterone decanoate,experimental,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C29H46O3,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB01481,1-Testosterone,experimental; illicit; investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C,C19H28O2,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone and derivatives, Testosterone Congeners", Androgen receptor
DB16002,Testosterone isocaproate,experimental,[H][C@@]12CC[C@H](OC(=O)CCC(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C25H38O3,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB16003,Testosterone phenylpropionate,experimental,[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C28H36O3,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB01485,4-Hydroxytestosterone,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(O)C(=O)CC[C@]12C,C19H28O3,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Steroids, Testosterone and derivatives, Testosterone Congeners",
DB01486,Cathine,experimental; illicit,C[C@H](N)[C@@H](O)C1=CC=CC=C1,C9H13NO,1,"Alcohols, Alimentary Tract and Metabolism, Amines, Amino Alcohols, Anti-Obesity Agents, Antiobesity Preparations, Excl. Diet Products, Appetite Depressants, Centrally Acting Antiobesity Products, Propanolamines, Propanols",
DB08804,Nandrolone decanoate,approved; illicit,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],C28H44O3,1,"Anabolic Agents, Androgens, Bone Density Conservation Agents, Estranes, Estrenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Nandrolone and esters, Steroids, Testosterone Congeners, Thyroxine-binding globulin inhibitors, UGT1A1 Substrates, UGT1A3 substrates, UGT1A4 substrates, UGT2B7 substrates"," Androgen receptor,  Proto-oncogene c-Fos,  5-hydroxytryptamine 2 receptor (Protein Group),  5-hydroxytryptamine receptor 1B,  Insulin-like growth factor 1 receptor,  Dopamine receptor (Protein Group),  Cytochrome P450 19A1,  Amine oxidase [flavin-containing] B,  Amine oxidase [flavin-containing] A,  UDP-glucuronosyltransferase 2B7,  UDP-glucuronosyltransferase 1-4,  UDP-glucuronosyltransferase 2B4,  UDP-glucuronosyltransferase 1-3,  UDP-glucuronosyltransferase 1-1,  UDP-glucuronosyltransferase 1-10,  Sex hormone-binding globulin"
DB06645,Anamorelin,investigational,CN(C)N(C)C(=O)[C@@]1(CC2=CC=CC=C2)CCCN(C1)C(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)C(C)(C)N,C31H42N6O3,1,"Amino Acids, Peptides, and Proteins, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptide Hormones, Peptides",
DB08807,Bopindolol,experimental,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1,C23H28N2O3,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Beta Blocking Agents, Non-Selective, Bradycardia-Causing Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Neurotransmitter Agents, Phenoxypropanolamines, Propanolamines, Propanols"," Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  5-hydroxytryptamine receptor 1A,  5-hydroxytryptamine receptor 1B,  Beta-3 adrenergic receptor,  Cytochrome P450 2D6"
DB01493,Ethylestrenol,withdrawn,[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],C20H32O,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Estren Derivatives, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Norpregnanes, Norpregnenes, Norsteroids, Steroids",
DB12948,Didox,investigational,ONC(=O)C1=CC(O)=C(O)C=C1,C7H7NO4,1,"Amines, Antineoplastic Agents, Enzyme Inhibitors, Hydroxy Acids, Hydroxylamines, Ribonucleotide Reductases, antagonists & inhibitors",
DB01500,Oxabolone,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C(O)=C3CC[C@@]21[H],C18H26O3,1,,
DB06666,Lixivaptan,investigational,CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C1,C27H21ClFN3O2,1,"Acids, Carbocyclic, Amides, Benzazepines, Benzene Derivatives, Benzoates, Heterocyclic Compounds, Fused-Ring",
DB12952,Methylprednisone,approved; investigational,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)CC(=O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,C22H28O5,1,"Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates", Cytochrome P450 3A4
DB01503,1-Androstenediol,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)C=C[C@]12C,C19H30O2,1,,
DB01509,Tenamfetamine,experimental; illicit,CC(N)CC1=CC2=C(OCO2)C=C1,C10H13NO2,1,"Adrenergic Agents, Adrenergic Uptake Inhibitors, Agents producing tachycardia, Agents that produce hypertension, Amines, Amphetamines, Antidepressive Agents, Central Nervous System Agents, Central Nervous System Depressants, Ethylamines, Hallucinogens, Membrane Transport Modulators, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Phenethylamines, Psychotropic Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents, Serotonin Modulators, Sympathomimetics",
DB01510,Dehydrochloromethyltestosterone,experimental; illicit,,,1,Testosterone and derivatives,
DB01514,Furazabol,illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NON=C3C[C@]12C,C20H30N2O2,1,"Androstanes, Fused-Ring Compounds, Steroids",
DB01521,Clostebol,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(Cl)C(=O)CC[C@]12C,C19H27ClO2,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB01524,Androstenediol,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,C19H30O2,1,"Anabolic Agents, Androstanes, Androstenediols, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB01526,4-Androstenediol,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C[C@@H](O)CC[C@]12C,C19H30O2,1,,
DB06701,Dexmethylphenidate,approved; investigational,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,C14H19NO2,1,"Agents that produce hypertension, Antidepressive Agents, Central Nervous System Agents, Central Nervous System Depressants, Central Nervous System Stimulants, Central Nervous System Stimulation, Centrally Acting Sympathomimetics, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Dopamine Agents, Dopamine Uptake Inhibitors, Membrane Transport Modulators, Methylphenidate and isomer, Nervous System, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Phenylacetates, Piperidines, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin Agents, Serotonin Modulators"," Sodium-dependent dopamine transporter,  Sodium-dependent noradrenaline transporter,  Sodium-dependent serotonin transporter,  Carboxylesterase"
DB01529,Dextromoramide,experimental; illicit,C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,C25H32N2O2,1,"Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Diphenylpropylamine Derivatives, Morpholines, Narcotics, Nervous System, Opioids, Oxazines, Peripheral Nervous System Agents, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",
DB01531,Desomorphine,experimental; illicit,[H][C@@]12CCC[C@@]3([H])[C@@]4([H])CC5=CC=C(O)C(O1)=C5[C@@]23CCN4C,C17H21NO2,1,"Alkaloids, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Heterocyclic Compounds, Fused-Ring, Illicit Drugs, Morphinans, Morphine Derivatives, Narcotics, Opiate Alkaloids, Opioids, Peripheral Nervous System Agents, Phenanthrenes, Sensory System Agents, Street Drugs",
DB01532,α-Methylacetylfentanyl,illicit,CC(CC1=CC=CC=C1)N1CCC(CC1)N(C(C)=O)C1=CC=CC=C1,C22H28N2O,1,,
DB06706,Isometheptene,approved,CNC(C)CCC=C(C)C,C9H19N,1,"Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-Agonists, Agents producing tachycardia, Agents that produce hypertension, Alimentary Tract and Metabolism, Amines, Drugs for Functional Gastrointestinal Disorders, Methemoglobinemia Associated Agents"," Alpha-1A adrenergic receptor,  Synaptic vesicular amine transporter"
DB01536,Androstenedione,experimental; illicit,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C19H26O2,1,"17-Ketosteroids, Adrenal Cortex Hormones, Androstanes, Androstenes, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Ketosteroids, Steroids, Testosterone Congeners"," Estradiol 17-beta-dehydrogenase 1,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  6-deoxyerythronolide B hydroxylase,  Aldo-keto reductase family 1 member C3,  Cytochrome P450 3A4,  Aldo-keto reductase family 1 member C3"
DB01537,"4-Bromo-2,5-dimethoxyphenethylamine",experimental; illicit,COC1=CC(Br)=C(OC)C=C1CCN,C10H14BrNO2,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-Agonists, Amines, Antidepressive Agents, Central Nervous System Depressants, Ethylamines, Neurotransmitter Agents, Phenethylamines, Serotonin Agents"," 5-hydroxytryptamine receptor 2C,  5-hydroxytryptamine receptor 2A"
DB06710,Methyltestosterone,approved,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,C20H30O2,1,"3-Oxoandrosten (4) Derivatives, Anabolic Agents, Androgens, Androgens and Estrogens, Androstanes, Androstenes, Androstenols, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, OAT3/SLC22A8 Inducers, Sex Hormones and Modulators of the Genital System, Steroids, Testosterone Congeners, Thyroxine-binding globulin inhibitors"," Androgen receptor,  Estrogen receptor alpha,  Cytochrome P450 2B6,  Cytochrome P450 3A4,  Cytochrome P450 19A1,  Serum albumin,  Sex hormone-binding globulin,  Solute carrier organic anion transporter family member 1A2,  Solute carrier family 22 member 8"
DB01540,17alpha-methyl-4-hydroxynandrolone,illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C(O)=C3CC[C@@]21[H],C19H28O3,1,,
DB01541,Boldenone,illicit; vet_approved,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C19H26O2,1,"Anabolic Agents, Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone and derivatives, Testosterone Congeners", Androgen receptor
DB06714,Propylhexedrine,approved,CNC(C)CC1CCCCC1,C10H21N,1,"Adrenergic Agonists, Adrenergic alpha-Agonists, Amines"," Synaptic vesicular amine transporter,  Trace amine-associated receptor 1"
DB01543,18-methyl-19-nortestosterone,experimental; illicit,[H][C@@]12CC[C@H](O)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],C19H28O2,1,Testosterone and derivatives,
DB06718,Stanozolol,approved; vet_approved,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12C,C21H32N2O,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Androgens, Androstan Derivatives, Androstanes, Androstanols, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Thyroxine-binding globulin inhibitors", Androgen receptor
DB06719,Buserelin,approved; investigational,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1,C60H86N16O13,1,"Adrenal Cortex Hormones, Amino Acids, Peptides, and Proteins, Antineoplastic Agents, Antineoplastic and Immunomodulating Agents, Endocrine Therapy, Fertility Agents, Fertility Agents, Female, Gonadotropin-releasing hormone agonist, Hormones, Hormones and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Hypothalamic Hormones, Miscellaneous Therapeutic Agents, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Pituitary Hormone-Releasing Hormones, Potential QTc-Prolonging Agents, Proteins, QTc Prolonging Agents, Reproductive Control Agents"," Lutropin-choriogonadotropic hormone receptor,  Gonadotropin-releasing hormone receptor,  Cytochrome P450 19A1"
DB01550,Fenproporex,experimental; illicit; withdrawn,CC(CC1=CC=CC=C1)NCCC#N,C12H16N2,1,"Amines, Drugs that are Mainly Renally Excreted, Ethylamines, Phenethylamines, Stimulants",
DB01556,Chlorphentermine,illicit; withdrawn,CC(C)(N)CC1=CC=C(Cl)C=C1,C10H14ClN,1,"Agents producing tachycardia, Agents that produce hypertension, Amines, Amphetamines, Autonomic Agents, Ethylamines, Peripheral Nervous System Agents, Phenethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics",
DB01557,α-Methylfentanyl,illicit,CCC(=O)N(C1CCN(CC1)C(C)CC1=CC=CC=C1)C1=CC=CC=C1,C23H30N2O,1,"Designer Drugs, Piperidines, Street Drugs",
DB01560,Cathinone,illicit,C[C@H](N)C(=O)C1=CC=CC=C1,C9H11NO,1,"Central Nervous System Agents, Central Nervous System Depressants, Central Nervous System Stimulants, Psychotropic Drugs",
DB01564,Calusterone,experimental; illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](C)CC2=CC(=O)CC[C@]12C,C21H32O2,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Steroids, Testosterone and derivatives, Testosterone Congeners", Androgen receptor
DB01565,Dihydromorphine,experimental; illicit,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O,C17H21NO3,1,"Alkaloids, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Heterocyclic Compounds, Fused-Ring, Morphinans, Morphine Derivatives, Narcotics, Opiate Alkaloids, Opioids, Peripheral Nervous System Agents, Phenanthrenes, Semi-synthetic Opioids, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"," Mu-type opioid receptor,  Delta-type opioid receptor,  Kappa-type opioid receptor,  E3 ubiquitin-protein ligase TRIM13,  Pro-opiomelanocortin"
DB08905,Formestane,approved; investigational; withdrawn,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(O)C(=O)CC[C@]12C,C19H26O3,1,"17-Ketosteroids, Adrenal Cortex Hormones, Androstanes, Androstenes, Antineoplastic Agents, Antineoplastic and Immunomodulating Agents, Aromatase Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Drugs that are Mainly Renally Excreted, Endocrine Therapy, Enzyme Inhibitors, Estrogen Antagonists, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormone Antagonists, Hormone Antagonists and Related Agents, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Ketosteroids, Steroid Synthesis Inhibitors, Steroids, Testosterone Congeners", Cytochrome P450 3A4
DB01569,Formebolone,experimental; illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C(C=O)=C[C@]12C,C21H28O4,1,"Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Steroids, Testosterone and derivatives", Corticosteroid 11-beta-dehydrogenase isozyme 2
DB01570,Ohmefentanyl,illicit,CCC(=O)N(C1CCN(CC(O)C2=CC=CC=C2)CC1C)C1=CC=CC=C1,C23H30N2O2,1,"Analgesics, Central Nervous System Agents, Peripheral Nervous System Agents, Piperidines, Sensory System Agents",
DB01571,3-Methylfentanyl,illicit,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1,C23H30N2O,1,"Analgesics, Central Nervous System Agents, Peripheral Nervous System Agents, Piperidines, Sensory System Agents"," Mu-type opioid receptor,  Delta-type opioid receptor,  Kappa-type opioid receptor"
DB01572,Methyl-1-testosterone,experimental; illicit,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C,C20H30O2,1,Testosterone and derivatives,
DB01573,Benzylmorphine,experimental; illicit,[H][C@@]12OC3=C(OCC4=CC=CC=C4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,C24H25NO3,1,,
DB08906,Fluticasone furoate,approved,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C27H29F3O6S,1,"Adrenal Cortex Hormones, Agents to Treat Airway Disease, Androstanes, Androstenes, Corticosteroids, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Fused-Ring Compounds, Glucocorticoids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Nasal Preparations, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein inducers, P-glycoprotein substrates, Steroids, Thyroxine-binding globulin inhibitors"," Glucocorticoid receptor,  Progesterone receptor,  Mineralocorticoid receptor,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  Cytochrome P450 3A7,  Cytochrome P450 2C8,  Corticosteroid-binding globulin,  Serum albumin,  Alpha-1-acid glycoprotein 1,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1B1"
DB01577,Metamfetamine,approved; illicit; withdrawn,CN[C@@H](C)CC1=CC=CC=C1,C10H15N,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic Uptake Inhibitors, Agents producing tachycardia, Agents that produce hypertension, Amines, Amphetamine Anorectic, Amphetamines, Antidepressive Agents, Appetite Suppression, Autonomic Agents, Central Nervous System Agents, Central Nervous System Depressants, Central Nervous System Stimulants, Central Nervous System Stimulation, Centrally Acting Sympathomimetics, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Dopamine Agents, Dopamine Uptake Inhibitors, Drugs that are Mainly Renally Excreted, Ethylamines, Increased Sympathetic Activity, Membrane Transport Modulators, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Nervous System, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Peripheral Nervous System Agents, Phenethylamines, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics"," Sodium-dependent dopamine transporter,  Sodium-dependent serotonin transporter,  Sodium-dependent noradrenaline transporter,  Synaptic vesicular amine transporter,  Chromaffin granule amine transporter,  Trace amine-associated receptor 1,  Alpha-2A adrenergic receptor,  Alpha-2B adrenergic receptor,  Alpha-2C adrenergic receptor, 10. Amine oxidase [flavin-containing] A, 11. Amine oxidase [flavin-containing] B,  Cytochrome P450 2D6,  Solute carrier family 22 member 3,  Solute carrier family 22 member 5"
DB01579,Phendimetrazine,approved; illicit,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1,C12H17NO,1,"Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-Agonists, Agents producing tachycardia, Agents that produce hypertension, Amphetamines, Appetite Suppression, Central Nervous System Agents, Central Nervous System Stimulants, Increased Sympathetic Activity, Oxazines, Sympathomimetic Amine Anorectic, Sympathomimetics"," Alpha-1A adrenergic receptor,  Sodium-dependent noradrenaline transporter,  Alpha-1B adrenergic receptor"
DB01580,Oxprenolol,approved,CC(C)NCC(O)COC1=CC=CC=C1OCC=C,C15H23NO3,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Anti-Anxiety Agents, Antiarrhythmic agents, Antihypertensive Agents, Autonomic Agents, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Beta Blocking Agents, Non-Selective, and Thiazides, Bradycardia-Causing Agents, Cardiovascular Agents, Central Nervous System Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Hypotensive Agents, Negative Inotrope, Neurotransmitter Agents, OCT2 Inhibitors, Peripheral Nervous System Agents, Phenoxypropanolamines, Propanolamines, Propanols, QTc Prolonging Agents, Sympatholytics, Tranquilizing Agents, Vasodilating Agents"," Beta-1 adrenergic receptor,  Beta-3 adrenergic receptor,  Beta-2 adrenergic receptor,  Cytochrome P450 2D6,  Solute carrier family 22 member 2"
DB16117,Buprenorphine hemiadipate,investigational,[H][C@@]12OC3=C4C(C[C@H]5N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3OC(=O)CCCCC(O)=O,C35H49NO7,1,,
DB08925,Adrafinil,withdrawn,ONC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,C15H15NO3S,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-Agonists, Agents producing tachycardia, Agents that produce hypertension, Amines, Hydroxy Acids, Hydroxylamines, Nervous System, Neurotransmitter Agents, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics, Sympathomimetic-like Agent",
DB16136,Dexisometheptene mucate,investigational,CN[C@H](C)CCC=C(C)C,C9H19N,1,,
DB16141,Dimethandrolone Undecanoate,investigational,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)C[C@H](C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H],C31H50O3,1,,
DB06788,Histrelin,approved; withdrawn,CC(O)=O.CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1=CN(CC2=CC=CC=C2)C=N1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,C70H94N18O16,1,"Adrenal Cortex Hormones, Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating Agents, Endocrine Therapy, Gonadotropin Releasing Hormone Receptor Agonist, Gonadotropin Releasing Hormone Receptor Agonists, Gonadotropin-releasing hormone agonist, Hormones, Hormones and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Hypothalamic Hormones, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Potential QTc-Prolonging Agents, Proteins, QTc Prolonging Agents", Gonadotropin-releasing hormone receptor
DB13074,Macimorelin,approved; investigational,CC(C)(N)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)NC=O,C26H30N6O3,1,"Amino Acids, Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Diagnostic Agents, Growth Hormone Secretagogue Receptor Agonist, Growth Hormone Secretagogue Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Tests for Pituitary Function"," Growth hormone secretagogue receptor type 1,  Cytochrome P450 3A4"
DB08971,Fluocortolone,approved; withdrawn,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C22H29FO4,1,"Adrenal Cortex Hormones, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids for Systemic Use, Plain, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Ophthalmologicals, Pregnadienediols, Pregnadienes, Pregnanes, Sensory Organs, Steroids, Steroids, Fluorinated, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Vasoprotectives"," Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB08973,Fluclorolone acetonide,approved; withdrawn,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(Cl)[C@@H](Cl)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,C24H29Cl2FO5,1,"Adrenal Cortex Hormones, Corticosteroids, Fused-Ring Compounds, Pregnadienes, Pregnanes, Steroids",
DB06825,Triptorelin,approved; vet_approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,C64H82N18O13,1,"Adrenal Cortex Hormones, Amino Acids, Peptides, and Proteins, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, Contraceptive Agents, Hormonal, Endocrine Therapy, Gonadotropin Releasing Hormone Receptor Agonist, Gonadotropin Releasing Hormone Receptor Agonists, Gonadotropin-releasing hormone agonist, Hormones, Hormones and Related Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Hypothalamic Hormones, Luteolytic Agents, Nerve Tissue Proteins, Neuropeptides, Oligopeptides, Peptide Hormones, Peptides, Pituitary Hormone-Releasing Hormones, Potential QTc-Prolonging Agents, Proteins, QTc Prolonging Agents, Reproductive Control Agents", Gonadotropin-releasing hormone receptor
DB08985,Etilefrine,approved; withdrawn,CCNCC(O)C1=CC=CC(O)=C1,C10H15NO2,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-Agonists, Adrenergic and Dopaminergic Agents, Adrenergic beta-1 Receptor Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Amines, Amino Alcohols, Autonomic Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy, Cardiotonic Agents, Cardiovascular Agents, Compounds used in a research, industrial, or household setting, Ethanolamines, Neurotransmitter Agents, Peripheral Nervous System Agents, Protective Agents, Sympathomimetics, Vasoconstrictor Agents",
DB08989,Etamivan,withdrawn,CCN(CC)C(=O)C1=CC(OC)=C(O)C=C1,C12H17NO3,1,"Acids, Carbocyclic, Amides, Benzene Derivatives, Benzoates, Respiratory System Agents",
DB13108,Mephedrone,investigational,CNC(C)C(=O)C1=CC=C(C)C=C1,C11H15NO,1,"Agents producing tachycardia, Agents that produce hypertension, Amines, Amphetamines, Ethylamines, Illicit Drugs, Phenethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Street Drugs, Sympathomimetics",
DB13139,Levosalbutamol,approved; investigational,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,C13H21NO3,1,"Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Amines, Amino Alcohols, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Drugs that are Mainly Renally Excreted, Ethanolamines, Ethylamines, OATP1B1/SLCO1B1 Substrates, OATP1B3 substrates, Phenethylamines"," Beta-2 adrenergic receptor,  Solute carrier organic anion transporter family member 1B1,  Solute carrier organic anion transporter family member 1B3"
DB09022,Benfluorex,investigational; withdrawn,CC(CC1=CC(=CC=C1)C(F)(F)F)NCCOC(=O)C1=CC=CC=C1,C19H20F3NO2,1,"Alimentary Tract and Metabolism, Amines, Anti-Obesity Agents, Appetite Depressants, Blood Glucose Lowering Agents, Drugs Used in Diabetes, Ethylamines, Hypolipidemic Agents, Lipid Regulating Agents, Oral Hypoglycemics, Phenethylamines",
DB06870,Tetrahydrogestrinone,experimental,[H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],C21H28O2,1,"Anabolic Agents, Androgens, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Norpregnanes, Norpregnatrienes, Norsteroids, Steroids", Androgen receptor
DB13169,Nandrolone,experimental; investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],C18H26O2,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Androgens, Estranes, Estren Derivatives, Estrenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Nandrolone and esters, Ophthalmologicals, Sensory Organs, Steroids, Testosterone Congeners, Thyroxine-binding globulin inhibitors",
DB16279,Pecavaptan,investigational,C[C@H](O)C1=NC(CN2N=C(N(C[C@H](O)C(F)(F)F)C2=O)C2=CC=C(Cl)C=C2)=NN1C1=CC(Cl)=CC=C1,C22H19Cl2F3N6O3,1,," Vasopressin V1a receptor,  Vasopressin V2 receptor"
DB01708,Prasterone,approved; investigational; nutraceutical,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C,C19H28O2,1,"17-Ketosteroids, Adjuvants, Immunologic, Adrenal Cortex Hormones, Alimentary Tract and Metabolism, Anabolic Agents for Systemic Use, Anabolic Steroids, Androgens and Estrogens, Androstan Derivatives, Androstanes, Androstenes, Androstenols, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Immunologic Factors, Ketosteroids, OATP1B1/SLCO1B1 Substrates, OATP1B3 substrates, OATP2B1/SLCO2B1 substrates, Sex Hormones and Modulators of the Genital System, Steroids, Testosterone Congeners"," Estrogen receptor alpha,  Estrogen receptor beta,  GABA(A) Receptor (Protein Group),  NMDA receptor (Protein Group),  Androgen receptor,  Peroxisome proliferator-activated receptor alpha,  Sigma non-opioid intracellular receptor 1,  Nuclear receptor subfamily 1 group I member 2,  Nuclear receptor subfamily 1 group I member 3,  Cytochrome P450 3A7,  Estradiol 17-beta-dehydrogenase 1,  Bile salt sulfotransferase,  Sulfotransferase family cytosolic 2B member 1,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  Cholesterol oxidase,  Steroid 17-alpha-hydroxylase/17,20 lyase,  Solute carrier organic anion transporter family member 1B3,  Solute carrier organic anion transporter family member 2B1,  Solute carrier organic anion transporter family member 1B1,  Solute carrier organic anion transporter family member 1A2,  Multidrug resistance-associated protein 1,  ATP-binding cassette sub-family G member 2,  Multidrug resistance-associated protein 4"
DB09069,Trimetazidine,approved; investigational,COC1=C(OC)C(OC)=C(CN2CCNCC2)C=C1,C14H22N2O3,1,"Cardiac Therapy, Cardiovascular Agents, Piperazines, Vasodilating Agents"," 3-ketoacyl-CoA thiolase, mitochondrial,  Serum albumin"
DB09070,Tibolone,approved; investigational,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC(=O)CC3)C[C@@]([H])(C)[C@@]21[H],C21H28O2,1,"Anabolic Agents, Antineoplastic Agents, Hormonal, Cardiovascular Agents, Estrogen Receptor Modulators, Estrogens, Estrogens, Antiestrogens, and Estrogen Agonist-Antagonists, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Hormone Antagonists, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Norpregnanes, Norsteroids, Sex Hormones and Modulators of the Genital System, Steroids"," Estrogen receptor alpha,  Steryl-sulfatase,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,  Sulfotransferase 1A1,  Serum albumin"
DB13185,Oxabolone cipionate,experimental,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=C(O)C(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,C26H38O4,1,"Alimentary Tract and Metabolism, Anabolic Agents for Systemic Use, Anabolic Steroids, Drugs that are Mainly Renally Excreted, Estradiol Congeners, Estranes, Estren Derivatives, Estrenes, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids",
DB09080,Olodaterol,approved,COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,C21H26N2O5,1,"Adrenergic Agonists, Adrenergic beta-1 Receptor Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Heterocyclic Compounds, Fused-Ring, Long-acting beta-adrenoceptor agonists, Oxazines, Peripheral Nervous System Agents, Potential QTc-Prolonging Agents, QTc Prolonging Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists"," Beta-2 adrenergic receptor,  Cytochrome P450 2C9,  Cytochrome P450 2C8"
DB09082,Vilanterol,approved,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl,C24H33Cl2NO5,1,"Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Agents to Treat Airway Disease, Alcohols, Benzene Derivatives, Benzyl Compounds, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Drugs for Obstructive Airway Diseases, Drugs that are Mainly Renally Excreted, Hydrocarbons, Chlorinated, Hydrocarbons, Halogenated, Immunosuppressive Agents, Long-acting beta-adrenoceptor agonists, P-glycoprotein substrates, Potential QTc-Prolonging Agents, QTc Prolonging Agents"," Beta-2 adrenergic receptor,  Cytochrome P450 3A4,  P-glycoprotein 1"
DB09095,Difluocortolone,approved; investigational; withdrawn,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C22H28F2O4,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids, Dermatological Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Dermatologicals, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Glucocorticoids, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Pregnadienediols, Pregnadienes, Pregnanes, Steroids, Steroids, Fluorinated"," Annexin A3,  Glucocorticoid receptor,  Cytochrome P450 3A4,  Cytochrome P450 3A5"
DB03962,Nicotinamide 8-bromo-adenine dinucleotide phosphate,experimental,[H]N([H])C(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C(Br)=NC3=C(N=CN=C23)N([H])[H])[C@@H](O)[C@H]1O,C21H27BrN7O17P3,1,," 6-phosphogluconate dehydrogenase, decarboxylating"
DB13238,Tuaminoheptane,experimental,CCCCCC(C)N,C7H17N,1,"Nasal Preparations, Sympathomimetics, Plain",
DB13251,Octopamine,experimental,NCC(O)C1=CC=C(O)C=C1,C8H11NO2,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-Agonists, Adrenergic and Dopaminergic Agents, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Amines, Amino Alcohols, Biogenic Amines, Biogenic Monoamines, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy, Cardiovascular Agents, Ethanolamines, Ethylamines, Neurotransmitter Agents, Phenethylamines, Vasoconstrictor Agents",
DB09168,4-Phenylfentanyl,illicit,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,C28H32N2O,1,,
DB09169,3-Allylfentanyl,illicit,CCC(=O)N([C@@H]1CCN(CCC2=CC=CC=C2)C[C@@H]1CC=C)C1=CC=CC=C1,C25H32N2O,1,Piperidines,
DB13285,Etilamfetamine,experimental,CCNC(C)CC1=CC=CC=C1,C11H17N,1,"Alimentary Tract and Metabolism, Antiobesity Preparations, Excl. Diet Products, Centrally Acting Antiobesity Products",
DB09170,β-Hydroxythiofentanyl,illicit,CCC(=O)N(C1CCN(CC(O)C2=CC=CS2)CC1)C1=CC=CC=C1,C20H26N2O2S,1,,
DB09171,β-Methylfentanyl,illicit,CCC(=O)N(C1CCN(CC(C)C2=CC=CC=C2)CC1)C1=CC=CC=C1,C23H30N2O,1,,
DB09173,Butyrfentanyl,illicit,CCCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,C23H30N2O,1,"Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Illicit Drugs, Piperidines, Street Drugs"," Mu-type opioid receptor,  Kappa-type opioid receptor,  Delta-type opioid receptor,  Cytochrome P450 3A4,  Cytochrome P450 2D6"
DB06987,(R)-Atenolol,experimental,CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1,C14H22N2O3,1,," Lactotransferrin,  Group IIE secretory phospholipase A2"
DB09177,p-Fluorofentanyl,illicit,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,C22H27FN2O,1,,
DB09180,Thienylfentanyl,illicit,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1)C1=CC=CC=C1,C20H26N2OS,1,,
DB09182,Benzylfentanyl,illicit,CCC(=O)N(C1CCN(CC2=CC=CC=C2)CC1)C1=CC=CC=C1,C21H26N2O,1,Piperidines,
DB16625,Prasterone enantate,approved,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OC(=O)CCCCCC,C26H40O3,1,"17-Ketosteroids, Adrenal Cortex Hormones, Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Ketosteroids, Steroids, Testosterone Congeners",
DB16629,Serdexmethylphenidate,approved,[H][C@@]1(CCCCN1C(=O)OC[N+]1=CC=CC(=C1)C(=O)N[C@@H](CO)C([O-])=O)[C@H](C(=O)OC)C1=CC=CC=C1,C25H29N3O8,1,"Agents that produce hypertension, Central Nervous System Agents, Central Nervous System Stimulants, Central Nervous System Stimulation, Centrally Acting Sympathomimetics, Dopamine Agents, Dopamine Uptake Inhibitors, Membrane Transport Modulators, Nervous System, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Phenylacetates, Piperidines, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics"," Sodium-dependent dopamine transporter,  Sodium-dependent noradrenaline transporter,  5-hydroxytryptamine receptor 1A,  Carboxylesterase"
DB01839,Propylene glycol,approved; investigational,CC(O)CO,C3H8O2,1,"Alcohols, Compounds used in a research, industrial, or household setting, Drug Delivery Systems, Glycols, Pegylated agents, Pharmaceutic Aids, Pharmaceutical Preparations, Pharmaceutical Vehicles, Propylene Glycols, Solvents", B12-independent glycerol dehydratase
DB16702,Famprofazone,experimental,CC(C)C1=C(CN(C)C(C)CC2=CC=CC=C2)N(C)N(C1=O)C1=CC=CC=C1,C24H31N3O,1,"Amines, Amphetamines, Analgesics, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Ethylamines, Phenethylamines, Pyrazoles, Sympathomimetics",
DB16741,Bortezomib D-mannitol,approved,[H][C@@]1(OB(O[C@]1([H])[C@H](O)CO)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=NC=CN=C1)[C@H](O)CO,C25H35BN4O8,1,"Antineoplastic Agents, Proteasome Inhibitors",
DB07027,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,experimental,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC(F)=C1,C21H24FN3O2,1,, Prothrombin
DB01873,Epothilone D,investigational,[H][C@]1(C\C=C(C)/CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)C(\C)=C\C1=CSC(C)=N1,C27H41NO5S,1,"Anti-Bacterial Agents, Antimitotic Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Lactones, Macrolides, Mitosis Modulators, Polyketides, Tubulin Modulators"," Tubulin alpha 3C/D chain,  Tubulin beta chain,  Tubulin beta-1 chain,  Tubulin beta-4B chain,  Tubulin beta-4A chain,  Tubulin alpha-4A chain,  Tubulin beta-3 chain,  Tubulin alpha-1C chain,  Tubulin alpha-8 chain, 10. Tubulin alpha-1B chain, 11. Tubulin alpha-1A chain,  Cytochrome P450 3A4"
DB16826,Repotrectinib,approved; investigational,C[C@H]1CNC(=O)C2=C3N=C(N[C@H](C)C4=CC(F)=CC=C4O1)C=CN3N=C2,C18H18FN5O2,1,"BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Substrates, Kinase Inhibitor, MATE 2 Inhibitors, MATE inhibitors, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein inhibitors, P-glycoprotein substrates, ROS1 tyrosine kinase inhibitors, Tyrosine Kinase Inhibitors, UGT1A1 Inhibitors"," Proto-oncogene tyrosine-protein kinase ROS,  High affinity nerve growth factor receptor,  BDNF/NT-3 growth factors receptor,  NT-3 growth factor receptor,  Cytochrome P450 2B6,  Cytochrome P450 2C8,  Cytochrome P450 2C9,  Cytochrome P450 2C19,  Cytochrome P450 3A4,  Cytochrome P450 3A5,  UDP-glucuronosyltransferase 1-1,  ATP-binding cassette sub-family G member 2,  Multidrug and toxin extrusion protein 2,  P-glycoprotein 1,  Solute carrier organic anion transporter family member 1B1"
DB09255,Dextran,approved; investigational; vet_approved,,,1,"Anticoagulants, Biopolymers, Blood and Blood Forming Organs, Blood and Related Products, Blood Substitutes, Blood Substitutes and Perfusion Solutions, Blood Substitutes and Plasma Protein Fractions, Carbohydrates, Compounds used in a research, industrial, or household setting, Dextrans, Drugs that are Mainly Renally Excreted, Glucans, Hematologic Agents, Increased Intravascular Volume, Macromolecular Substances, Osmotic Activity, Plasma Substitutes, Polymers, Polysaccharides",
DB13378,Norfenefrine,experimental,NCC(O)C1=CC(O)=CC=C1,C8H11NO2,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-Agonists, Adrenergic and Dopaminergic Agents, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Amines, Amino Alcohols, Biogenic Amines, Biogenic Monoamines, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy, Ethanolamines, Ethylamines, Neurotransmitter Agents, Phenethylamines",
DB09287,Polyethylene glycol,approved; vet_approved,,,1,"Alcohols, Alimentary Tract and Metabolism, Compounds used in a research, industrial, or household setting, Drug Delivery Systems, Drugs for Constipation, Electrolytes, Ethylene Glycols, Excipients, Gastrointestinal Agents, Glycols, Laxatives, Macromolecular Substances, Osmotic Activity, Osmotic Laxatives, P-glycoprotein inhibitors, Pegylated agents, Pharmaceutic Aids, Pharmaceutical Preparations, Pharmaceutical Vehicles, Polyethylene Glycols, Polymers, Solvents, Stimulation Large Intestine Fluid/Electrolyte Secretion, Surface-Active Agents", P-glycoprotein 1
DB13415,Pentetrazol,experimental; withdrawn,C1CCN2N=NN=C2CC1,C6H10N4,1,"Azepines, Central Nervous System Agents, Central Nervous System Stimulants, Convulsants, GABA Agents, GABA Antagonists, Neurotransmitter Agents, Respiratory System Agents",
DB09315,Xenon-133,approved,[133Xe],Xe,1,"Diagnostic Radiopharmaceuticals, Elements, Gases, Inhalation Diagnostic Agent, Isotopes, Noble Gases, Radioisotopes, Radiopharmaceutical Activity, Xenon Isotopes",
DB07117,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",experimental,O=C1NC(=O)C(N2CCN(CC2)C2=NC=CC=N2)(C(=O)N1)C1=CC=C(OC2=CC=CC=C2)C=C1,C24H22N6O4,1,, Matrix metalloproteinase-9
DB04152,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",experimental,N[C@@H](CC1=CCCCC2=C1C(=O)NO2)C(O)=O,C11H14N2O4,1,, Glutamate receptor 2
DB13438,Prolintane,experimental,CCCC(CC1=CC=CC=C1)N1CCCC1,C15H23N,1,"Central Nervous System Agents, Central Nervous System Stimulants, Nervous System, Psychoanaleptics, Psychostimulants, Agents Used for ADHD and Nootropics",
DB13443,Esatenolol,experimental,CC(C)NC[C@H](O)COC1=CC=C(CC(N)=O)C=C1,C14H22N2O3,1,"Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Antihypertensive Agents, Beta Blocking Agents, Selective, Bradycardia-Causing Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates", Cytochrome P450 2D6
DB13453,Xenon,experimental,[Xe],Xe,1,"Agents that produce hypertension, Anesthetics, Anesthetics, General, Anesthetics, Inhalation, Central Nervous System Agents, Central Nervous System Depressants, Elements, Gases, Nervous System, Noble Gases",
DB13454,Nicomorphine,experimental,[H][C@@]12OC3=C(OC(=O)C4=CN=CC=C4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@]2([H])OC(=O)C1=CN=CC=C1,C29H25N3O5,1,"Alkaloids, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Heterocyclic Compounds, Fused-Ring, Morphinans, Narcotics, Natural Opium Alkaloids, Nervous System, Opiate Alkaloids, Opioids, Peripheral Nervous System Agents, Phenanthrenes, Pyridines, Sensory System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome",
DB16927,S-Apomorphine,investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=C1C(CCN2C)=CC=C3,C17H17NO2,1,,
DB09351,Levobetaxolol,approved; investigational,CC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1,C18H29NO3,1,"Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Bradycardia-Causing Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates"," Beta-1 adrenergic receptor,  Cytochrome P450 2D6"
DB13472,Cyclofenil,experimental,CC(=O)OC1=CC=C(C=C1)C(=C1CCCCC1)C1=CC=C(OC(C)=O)C=C1,C23H24O4,1,"Benzene Derivatives, Cresols, Fertility Agents, Fertility Agents, Female, Genito Urinary System and Sex Hormones, Ovulation Stimulants, Synthetic, Phenols, Reproductive Control Agents, Selective Estrogen Receptor Modulators, Sex Hormones and Modulators of the Genital System",
DB09378,Fluprednisolone,approved,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,C21H27FO5,1,"Adrenal Cortex Hormones, Anti-Inflammatory Agents, Corticosteroids, Corticosteroids for Systemic Use, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Immunosuppressive Agents, Pregnadienes, Pregnadienetriols, Pregnanes, Steroids, Steroids, Fluorinated", Cytochrome P450 3A4
DB09383,Meprednisone,approved; investigational,[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3([H])C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO,C22H28O5,1,"Adrenal Cortex Hormones, Corticosteroids, Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 Substrates, Fused-Ring Compounds, Glucocorticoids, Hyperglycemia-Associated Agents, Immunosuppressive Agents, Pregnadienediols, Pregnadienes, Pregnanes, Steroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Thyroxine-binding globulin inhibitors"," Cytochrome P450 3A4,  Cytochrome P450 3A5,  Serum albumin"
DB13484,Quinbolone,experimental,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC1=CCCC1,C24H32O2,1,"Alimentary Tract and Metabolism, Anabolic Agents for Systemic Use, Anabolic Steroids, Androstan Derivatives, Androstanes, Androstenes, Fused-Ring Compounds, Steroids",
DB04230,Nitromethyldethia coenzyme A,experimental,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCC[N+]([O-])=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1,C22H37N8O18P3,1,," Citrate synthase, mitochondrial"
DB09461,Xenon Xe-127,approved,[127Xe],Xe,1,"Elements, Gases, Inhalation Diagnostic Agent, Isotopes, Noble Gases, Radioactive Diagnostic Agent, Radioisotopes, Radiopharmaceutical Activity, Xenon Isotopes",
DB13515,Levomethadone,experimental,CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,C21H27NO,1,"Drugs Used in Addictive Disorders, Drugs Used in Opioid Dependence, Nervous System",
DB13530,Mepindolol,experimental,CC(C)NCC(O)COC1=CC=CC2=C1C=C(C)N2,C15H22N2O2,1,"Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-Antagonists, Agents causing hyperkalemia, Alcohols, Amines, Amino Alcohols, Beta Blocking Agents, Non-Selective, Bradycardia-Causing Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 Substrates, Neurotransmitter Agents, Phenoxypropanolamines, Propanolamines, Propanols", Cytochrome P450 2D6
DB13533,Methylestrenolone,experimental,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C,C19H28O2,1,"Adrenal Cortex Hormones, Estranes, Estren Derivatives, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Progesterone Congeners, Progestins, Sex Hormones and Modulators of the Genital System, Steroids",
DB02069,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,experimental,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC=C1F,C14H13FN2O3S,1,, Carbonic anhydrase 2
DB09571,Levmetamfetamine,approved,CN[C@H](C)CC1=CC=CC=C1,C10H15N,1,, Phenylethanolamine N-methyltransferase
DB13560,Dextranomer,experimental,,,1,"Biopolymers, Carbohydrates, Cicatrizants, Compounds used in a research, industrial, or household setting, Dermatologicals, Glucans, Macromolecular Substances, Polymers, Polysaccharides, Preparations for Treatment of Wounds and Ulcers, Sorption Detoxification",
DB13561,Clobenzorex,experimental,C[C@@H](CC1=CC=CC=C1)NCC1=CC=CC=C1Cl,C16H18ClN,1,"Alimentary Tract and Metabolism, Amines, Antiobesity Preparations, Excl. Diet Products, Central Nervous System Stimulants, Centrally Acting Antiobesity Products, Ethylamines, Phenethylamines",
DB13574,Heptaminol,experimental,CC(N)CCCC(C)(C)O,C8H19NO,1,"Alcohols, Amines, Amino Alcohols, Cardiac Therapy, Vasodilators Used in Cardiac Diseases",
DB11077,Polyethylene glycol 400,approved,,,1,"Alcohols, Artificial Tears, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted, EENT Drugs, Miscellaneous, Ethylene Glycols, Glycols, Macromolecular Substances, P-glycoprotein inhibitors, Pegylated agents, Polymers"," Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,  Oxidoreductase HTATIP2,  Cytochrome P450 4A11,  Alcohol dehydrogenase class-3,  Sulfotransferase 1A1,  P-glycoprotein 1"
DB13586,Metandienone,experimental; withdrawn,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C20H28O2,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Androgens for Topical Use, Androstadienes, Androstan Derivatives, Androstanes, Androstenes, Dermatologicals, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids",
DB13587,Mesterolone,experimental,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C[C@H](C)[C@]12C,C20H32O2,1,"5-Androstanon (3) Derivatives, Anabolic Agents, Androgens, Androstanes, Androstanols, Fused-Ring Compounds, Genito Urinary System and Sex Hormones, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Sex Hormones and Modulators of the Genital System, Steroids, Testosterone Congeners",
DB04325,Phenethylamine,experimental,NCCC1=CC=CC=C1,C8H11N,1,"Amines, Central Nervous System Agents, Central Nervous System Depressants, Ethylamines, Psychotropic Drugs"," Primary amine oxidase,  Trypsin-1,  Trypsin-2"
DB04331,Monastrol,experimental,CCOC(=O)C1=C(C)NC(=S)N[C@H]1C1=CC=CC(O)=C1,C14H16N2O3S,1,"Antimitotic Agents, Antineoplastic Agents, Enzyme Inhibitors, Mitosis Modulators, Sulfur Compounds", Kinesin-like protein KIF11
DB11124,Racepinephrine,approved,,,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic beta-1 Receptor Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-3 Receptor Agonists, Adrenergic beta-Agonists, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Alpha-and Beta-adrenergic Agonists, Amines, Amino Alcohols, Anti-Asthmatic Agents, Autonomic Agents, Benzene Derivatives, Biogenic Amines, Biogenic Monoamines, Bronchodilator Agents, Cardiovascular Agents, Catecholamines, Catechols, Epinephrine and similars, Ethanolamines, Mydriatics, Neurotransmitter Agents, Peripheral Nervous System Agents, Phenols, Respiratory System Agents, Sympathomimetics, Vasoconstrictor Agents"," Alpha-1A adrenergic receptor,  Alpha-1B adrenergic receptor,  Alpha-2A adrenergic receptor,  Alpha-2B adrenergic receptor,  Alpha-2C adrenergic receptor,  Beta-1 adrenergic receptor,  Beta-2 adrenergic receptor,  Alpha-1D adrenergic receptor,  Beta-3 adrenergic receptor"
DB17152,DRF-1042,investigational,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(C(OCCO)C3=CC4=CC=CC=C4N=C13)C2=O,C22H20N2O6,1,Alkaloids,
DB02159,(R)-Propylene glycol,experimental,C[C@@H](O)CO,C3H8O2,1,," Isocitrate dehydrogenase [NADP],  Lysozyme C"
DB17202,Apomorphine palmitate,investigational,[H][C@@]12CC3=C(C(OC(=O)CCCCCCCCCCCCCCC)=C(OC(=O)CCCCCCCCCCCCCCC)C=C3)C3=C1C(CCN2C)=CC=C3,C49H77NO4,1,,
DB11161,Polyethylene glycol 300,approved,,,1,"Alcohols, Compounds used in a research, industrial, or household setting, Ethylene Glycols, Glycols, Macromolecular Substances, Polymers",
DB13653,Lorcainide,experimental,CC(C)N1CCC(CC1)N(C(=O)CC1=CC=CC=C1)C1=CC=C(Cl)C=C1,C22H27ClN2O,1,"Acetamides, Amides, Antiarrhythmic agents, Antiarrhythmics, Class I, Antiarrhythmics, Class Ic, Benzene Derivatives, Cardiac Therapy, Cardiovascular Agents, Moderate Risk QTc-Prolonging Agents, QTc Prolonging Agents",
DB13655,Nikethamide,experimental,CCN(CC)C(=O)C1=CN=CC=C1,C10H14N2O,1,"Central Nervous System Agents, Central Nervous System Stimulants, Convulsants, Nicotinic Acids, Pyridines, Respiratory System Agents, Vitamin B Complex, Vitamins",
DB11208,Aluminum chlorohydrex propylene glycol,approved,,,1,,
DB07373,Boldione,experimental,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,C19H24O2,1,"Androstanes, Androstenes, Fused-Ring Compounds, Steroids", Pentaerythritol tetranitrate reductase
DB17384,Tinengotinib,investigational,CC1=C2N=C(C3=CC=CC=C3Cl)C3=C(NC2=NN1)C=C(N=C3)N1CCOCC1,C20H19ClN6O,1,,
DB17386,Xenon Xe-129,approved,[129Xe],Xe,1,"Contrast Media, Diagnostic Uses of Chemicals, Hyperpolarized Contrast Agent, Magnetic Resonance Imaging Contrast Media, Noble Gases, Xenon Isotopes",
DB13692,Tretoquinol,experimental,COC1=CC(C[C@@H]2NCCC3=CC(O)=C(O)C=C23)=CC(OC)=C1OC,C19H23NO5,1,"Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-Agonists, Adrenergics for Systemic Use, Adrenergics, Inhalants, Agents producing tachycardia, Agents that produce hypertension, Anti-Asthmatic Agents, Autonomic Agents, Benzylisoquinolines, Bronchodilator Agents, Drugs for Obstructive Airway Diseases, Heterocyclic Compounds, Fused-Ring, Isoquinolines, Neurotransmitter Agents, Peripheral Nervous System Agents, Respiratory System Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetics",
DB11236,Polyethylene glycol 3500,experimental,,,1,,
DB13710,Metenolone,experimental,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])CC(=O)C=C(C)[C@]4(C)[C@@]3([H])CC[C@]12C,C20H30O2,1,"Alimentary Tract and Metabolism, Anabolic Agents, Anabolic Agents for Systemic Use, Anabolic Steroids, Androstan Derivatives, Androstanes, Androstenes, Androstenols, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Steroids, Testosterone Congeners",
DB13723,Meldonium,experimental,C[N+](C)(C)NCCC([O-])=O,C6H14N2O2,1,"Adjuvants, Immunologic, Cardiac Therapy, Cardiovascular Agents, Hydrazines, Immunologic Factors",
DB11278,DL-Methylephedrine,approved,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C,C11H17NO,1,"Adrenergic Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Agents producing tachycardia, Agents that produce hypertension, Alcohols, Amines, Amino Alcohols, Drugs that are Mainly Renally Excreted, Ethylamines, Phenethylamines, Propanolamines, Propanols"," Beta-1 adrenergic receptor,  Alpha-2A adrenergic receptor,  Alpha adrenergic receptor (Protein Group),  Beta adrenergic receptor (Protein Group)"
DB07419,S-23,experimental,C[C@](O)(COC1=CC=C(Cl)C(F)=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,C18H13ClF4N2O3,1,"Amides, Amines, Aniline Compounds, Heterocyclic Compounds, Fused-Ring, Isoquinolines", Androgen receptor
DB07423,Andarine,experimental,CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC=C(C(=C2)C(F)(F)F)[N+]([O-])=O)C=C1,C19H18F3N3O6,1,"Acetates, Acids, Acyclic, Amides, Amines, Aniline Compounds, Benzene Derivatives, Phenols", Androgen receptor
